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SUMMARY 
Senescent cells play important physiological- and pathophysiological roles in tumor 
suppression, tissue regeneration, and aging. While select genetic and epigenetic 
elements crucial for senescence induction were identified, the dynamics, underlying 
epigenetic mechanisms, and regulatory networks defining senescence competence, 
induction and maintenance remain poorly understood, precluding a deliberate 
therapeutic manipulation of these dynamic processes. Here, we show, using dynamic 
analyses of transcriptome and epigenome profiles, that the epigenetic state of 
enhancers predetermines their sequential activation during senescence. We 
demonstrate that activator protein 1 (AP-1) ‘imprints’ the senescence enhancer 
landscape effectively regulating transcriptional activities pertinent to the timely execution 
of the senescence program. We define and validate a hierarchical transcription factor 
(TF) network model and demonstrate its effectiveness for the design of senescence 
reprogramming experiments.  Together, our findings define the dynamic nature and 
organizational principles of gene-regulatory elements driving the senescence program 
and reveal promising inroads for therapeutic manipulation of senescent cells. 
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INTRODUCTION 
Cellular senescence plays beneficial roles during embryonic development, wound 
healing, and tumor suppression. Paradoxically, it is also considered a significant 
contributor to aging and age-related diseases including cancer and degenerative 
pathologies1. As such, research on therapeutic strategies exploiting senescence 
targeting (e.g., senolytics, senomorphics or pro-senescence cancer therapies) to 
improve healthspan has gained enormous momentum in recent years2. 
 Cellular senescence is a cell fate that stably arrests proliferation of damaged and 
dysfunctional cells as a complex stress response. The most prominent inducers of 
senescence are hyper-activated oncogenes (oncogene-induced senescence, OIS)3. The 
senescence arrest is accompanied by widespread changes in gene expression, 
including a senescence-associated secretory phenotype (SASP) – the expression and 
secretion of inflammatory cytokines, growth factors, proteases, and other molecules, 
which exert pleiotropic effects on senescent cells themselves as well as the surrounding 
tissue4. Importantly, although activation of the senescence program can pre-empt the 
initiation of cancer, the long-term effects of the SASP make the local tissue environment 
more vulnerable to the spread of cancer and other age-related diseases. Therefore, 
therapeutic interventions aimed at limiting SASP production are of relevance for cancer 
and many age-related diseases4-6. 
 The knowledge on epigenetic mechanisms underlying senescence has only 
recently increased revealing significant contributions of select transcription factors (TFs), 
chromatin modifiers and structural components, as well as non-coding RNAs to the 
senescent phenotype7-12. A major limitation of such studies, however, was their 
restriction to start-end-point comparisons, ignoring the dynamic nature of the 
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senescence fate transition. Consequently, critical gene-regulatory aspects of the 
execution and maintenance of the senescence state remain poorly understood. 
Therefore, an integrative, temporally resolved, multidimensional profiling approach is 
required to establish essential regulatory principles that govern this key biological 
decision-making process. Such knowledge would be instrumental both for identifying 
stage-specific senescence regulators and urgently needed specific biomarkers as well 
as control points in TF and gene regulatory networks, which would pave the way for a 
deliberate therapeutic manipulation of the senescence cell fate. 
 Enhancers are key genomic regions that drive cell fate transitions. The enhancer 
landscape is established during development by the concerted action of TF networks 
and chromatin modifiers13.  The details on how this information converges in cis remain 
unclear, and we still lack valid organizational principles that explain the function of 
mammalian TF networks. In mammalian cells, enhancer elements are broadly divided 
into two major categories -active and poised. While active enhancers are characterized 
by the simultaneous presence of H3K4me1 together with H3K27ac and are associated 
with actively transcribed genes, only H3K4me1 marks poised enhancers, and their 
target genes are generally not expressed14. A subset of enhancers may also be 
activated de novo from genomic areas devoid of any TF binding and histone 
modifications. These latent or nascent enhancers serve an adaptive role in mediating 
stronger and faster gene expression upon cycles of repeated stimulation15,16. Recent 
evidence showed a role for enhancer remodeling in driving senescence-associated gene 
expression11,12,17. However, it is currently unknown which enhancer elements, epigenetic 
marks or TFs render cells competent to respond to senescence-inducing signals with 
precise timing and output. A thorough understanding of how senescence competence is 
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established, realized and what defines it would allow for the prediction of a positive 
senescence engagement for example in pro-senescence cancer therapies18.  
 Pioneer TFs are critical in establishing new cell fate competence by granting long-
term chromatin access to non-pioneer factors and are also crucial determinants of cell 
identity through their opening and licensing of the enhancer landscape19,20. We can now 
reliably deduce pioneer and non-pioneer TF activity from chromatin accessibility data 
allowing for the hierarchization of TF function whereby pioneer TFs sit atop a TF binding 
hierarchy, recruiting non-pioneers such as settler and migrant TFs to gene-regulatory 
regions for optimal transcriptional output21. The pioneer TFs bestowing senescence 
potential have not been identified to date. However, their identification might be a pre-
requisite for reprogramming or manipulation of senescent cells for future therapeutic 
benefit as was shown successfully for the reprogramming to adopt full stem cell 
identity22.  
 In this study, we examined the possibility that the epigenetic state of enhancers 
could determine senescence cell fate. We explored this question by generating time-
resolved transcriptomes and comprehensive epigenome profiles during oncogenic RAS-
induced senescence. Through integrative analysis and further functional validation, we 
revealed novel and unexpected links between enhancer chromatin, TF recruitment, and 
senescence potential and defined the organizational principles of the TF network that 
drive the senescence program. Together, this allowed us to precisely manipulate the 
senescence phenotype with important therapeutic implications. Specifically, we show 
that the senescence program is predominantly encoded at the enhancer level and that 
the enhancer landscape is dynamically reshaped at each step of the senescence 
transition. Remarkably, we find that this process is pre-determined before senescence 
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induction and AP-1 acts as a pioneer TF that ‘premarks’ prospective senescence 
enhancers to direct and localize the recruitment of other transcription factors into a 
hierarchical TF network that drives the senescence transcriptional program after 
induction. We also uncover a class of enhancers that retain an epigenomic memory after 
their inactivation during the senescence transition. These “remnant” enhancers lack 
traditional enhancer histone-modification marks but are instead “remembered” by AP-1 
TF bookmarking for eventual future re-activation. Finally, functional perturbation of 
prospective senescence enhancers and AP-1 validated and underscored the importance 
of these entities for the timely execution of the senescence gene expression program 
and allowed for the precise reprogramming and reversal of the senescence cell fate. 
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RESULTS 
We employed time-series experiments on WI38 fibroblasts undergoing oncogene-
induced senescence (OIS) using a tamoxifen-inducible ER: RASV12 expression 
system23. We determined global gene expression profiles by microarrays and mapped 
the full set of accessible chromatin sites by ATAC-seq24 at 6-time points (0, 24, 48, 72, 
96 and 144 h). Cells intended for ChIP-seq were crosslinked at 3-time-points (0, 72 and 
144h) and used for profiling histone modifications including H3K4me1 (putative 
enhancers), H3K4me3 (promoters), H3K27ac (active enhancers and promoters) and 
H3K27me3 (polycomb repressed chromatin). From accessible chromatin regions 
determined by ATAC-seq we deduced TF binding dynamics and hierarchies (Figure 1A). 
For comparison, we included cells undergoing quiescence (Q) by serum withdrawal for 
up to 96h. Unlike senescence arrested cells, quiescence arrested cells can be triggered 
to re-enter the cell cycle upon serum addition. Q and OIS cells were validated using 
classical markers (Supplementary Figures 1A-B).  
 
Multi-state establishment of the senescence transcriptional program  
To identify and visualize dynamic gene expression patterns across the entire Q and 
RAS-OIS time-courses, we employed an unsupervised, self-organizing map (SOM) 
machine learning technique25 (Figure 1B) and multidimensional scaling (MDS) (Figure 
1C) to our transcriptome data sets. Remarkably, serum-deprived fibroblasts rapidly 
established a Q-specific gene expression program within 24 h after serum deprivation, 
which changed only marginally within the remainder of the time-course (Figure 1B, left 
column and Figure 1C), and mainly involves only up-regulated (Figure 1B, top right 
corner, red) and down-regulated (Figure 1B, bottom left corner, blue) genes. By 
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contrast, fibroblasts undergoing RAS-OIS displayed dynamic gene expression 
trajectories that evolved steadily, both for up- (red) and down-regulated metagenes 
(blue) (Figures 1B, right column and Figure 1C). Thus, RAS-OIS, unlike Q, is highly 
dynamic and does not gyrate towards a stable transcriptome end state. To substantiate 
this further we calculated the diversity and specialization of transcriptomes and gene 
specificity26 (Figure 1D) and performed a kernel density estimation analysis 
(Supplementary Figure 1C). These analyses demonstrated that RAS-OIS cells exhibit a 
temporally evolving increase in transcriptional diversity, whereas Q cells exhibit a 
temporally evolving, specific gene expression program. We conclude that the RAS-OIS 
cell fate is an open-ended succession of cell states rather than a fixed cell fate with a 
defined end-point, which is the current tenet. The apparent open-endedness and 
transcriptional diversity may provide a fertile soil for the eventual escape of pre-
cancerous senescent cells as previously shown27,28. 
 To further delineate the evolution of the RAS-OIS gene expression program, we 
next performed dynamic differential gene expression analysis on the Q and OIS 
datasets29. A total of 4,986 genes (corresponding to 2,931 up-regulated and 2,055 
down-regulated genes) were differentially regulated in at least one-time point (with a 
minimal leading log2 fold-change of 1.2; q=5*10-4) and partitioned into seven (I-VII) gene 
expression modules with distinct functional overrepresentation profiles in line with the 
senescence phenotype (Figures 1E-F and Figure S1D). The highly reproducible 
dynamics of gene expression during RAS-OIS transition suggest a high degree of 
preprogramming of this succession of cell states. 
 Cell-fate decisions are typically associated with stable changes in gene 
expression that shift the regulatory system from one steady state to the next30. In line 
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with this, we found that proliferation-promoting genes of modules II and IV (E2F targets 
and G2M checkpoint) became increasingly repressed (i.e. senescence arrest), while 
pro-senescent SASP genes of modules VI and VII (e.g., inflammatory and interferon 
response genes) became persistently induced (Figure 1F and Supplementary Figure 
1E). Apoptosis-related genes of module III were repressed very early on in the time-
course (within the first 24-48 hours during RAS-OIS induction), which is surprising given 
that apoptosis-resistance is considered a very late event in senescence (Figure 1F and 
Supplementary Figure 1E). This indicates that the commitment to senescence is a very 
early event made at the expense of apoptosis. Finally, we identified a set of genes in 
modules I and V that would have gone unnoticed in a traditional start-end-point analysis 
because they follow an ‘‘impulse’’-like pattern. In these modules, transcript levels 
spiked-up (module V) or down (module I) following RAS-OIS induction, then sustained a 
new level, before transitioning to a new steady state, similar to the original levels 
(Figures 1E and Supplementary Figure 1E).  These expression patterns support the 
notion that genes of module V play an active and vital role early in the transition to RAS-
OIS, while genes in module I hold key regulators to maintain the proliferative fibroblast 
state.  
 Altogether, our investigation of transcriptome dynamics defined a modular 
organization and transcriptional diversity of the RAS-OIS gene expression program, 
providing a framework to unravel the gene-regulatory code underlying the senescence 
process.  
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A dynamic enhancer program shapes the senescence transcriptome 
Senescence cell fate involves a global remodeling of chromatin and specifically, the 
enhancer landscape11,12. An unanswered question, however, is how TFs and epigenetic 
modifications cooperatively shape a transcriptionally permissive enhancer landscape 
prior to gene activation to endow the cell with senescence potential. 
 To provide mechanistic insight into this question, we first comprehensively 
mapped genomic regulatory elements (i.e. putative enhancers, promoters and 
polycomb-repressed chromatin) during the transition of proliferating cells to RAS-OIS, 
profiling genome-wide histone modifications by ChIP-seq and transposon-accessible 
chromatin by ATAC-seq. To capture and quantify chromatin state dynamics we used 
ChromstaR (see Materials and Methods), which identified a total of sixteen chromatin 
states (Supplementary Figure 2A). The majority of the genome (≈80%) was, irrespective 
of the time-point, either devoid of any of the histone modifications analyzed (≈62%) or 
polycomb-repressed (≈18%). The fraction of the genome represented by active and 
accessible chromatin states (i.e., enhancers and promoters) was comparably lower 
(≈20% combined). Chromatin state transitions occurred most prominently at enhancers, 
while promoters were only mildly affected (Figures 2A-B and Supplementary Figure 2A, 
arrows) congruent with previous results11. Unexpectedly, we found, however, that most 
of the enhancer activation, i.e. acquisition of H3K4me1 and H3K27ac, occurred de novo 
from unmarked chromatin at the T0-72 h and 72 h-144 h intervals, followed by the more 
stereotypical enhancer activation from a poised state (H3K4me1+ plus H3K27ac 
acquisition) and enhancer poising from the unmarked and polycomb-repressed state at 
the T0-72 h interval (acquisition of H3K4me1) (Figures 2A and -B). Thus, the regulatory 
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landscape of senescence is largely predetermined by sequential enhancer activation 
from de novo and poised enhancers implying the existence of a prior imprint of past cell 
fate decisions. 
 The (in)activation chronology of enhancers was highly concordant with the 
temporal expression pattern of the nearest genes, indicating that most of these elements 
indeed function as bona fide enhancers (Supplementary Figure 2B). In line with this, 
correspondence analysis (CA) (Supplementary Figure 2C) revealed a strong correlation 
between gene expression modules (Figure 1E) and chromatin state transitions (Figure 
2A). For example, globally up-regulated transcriptomic modules V, VI, VII projected 
proximally to chromatin state transitions involving enhancer activation congruent with the 
installation of the SASP. By contrast, dynamic enhancer inactivation associated with 
repressed transcriptomic modules (II, III, IV) congruent with installation of the 
senescence arrest. Finally, the oscillatory expression of genes in the module I 
associated with an equally oscillatory activation of its closest enhancers. Therefore, 
dynamic remodeling of the enhancer landscape reflects and defines the modular and 
dynamic nature of the RAS-OIS gene expression program. 
 We next addressed the question of which TFs are key drivers for the dynamic 
enhancer remodeling driving the senescence transcriptome. To this end, we first 
intersected ATAC-seq peaks with the identified enhancer coordinates (Figure 2A-B) and 
performed a motif over-representation test. This analysis identified AP-1 super-family 
members (cJUN, FOS, FOSL1, FOSL2, BATF) as well as AP-1-associated TFs ATF3 
and ETS1 as the most enriched motifs at any given time-point, thus, hinting at a putative 
chromatin priming and pioneer function for these TFs (Supplementary Figure 2D). 
Because AP-1 TFs are essential and inducible downstream effectors for the RAS 
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signaling pathway in cellular transformation31 the possibility remains that the observed 
enrichment of AP-1 TFs at enhancers is strictly dependent on oncogenic RAS signaling 
per se and not a reflection of a specific pioneering role in the enhancer landscape 
independent of RAS signaling. We therefore performed the same analysis in cells 
undergoing replicative senescence (which is driven by loss of telomere integrity) and 
also in growth factor-deprived (and thus RAS signaling-muted) quiescent cells 
(Supplementary Figures 2E-F). In both cases, the AP-1 motif ascended as the 
predominant motif enriched at enhancers, thus, corroborating the notion that AP-1 TFs 
act as the universal pioneers imprinting the global as well as senescence-associated 
enhancer landscape.  
 To elaborate this further, we analyzed our time-resolved ATAC-seq data sets by 
adapting the “Protein Interaction Quantitation (PIQ)” algorithm, which was developed 
initially for DNAse-seq-based digital TF footprinting21. Importantly, PIQ allows for the 
functional hierarchization of TFs into pioneers, settlers, and migrants - whereby pioneer 
TFs bind nucleosome-compacted chromatin to initiate chromatin remodeling and to 
enable subsequent binding of non-pioneers (i.e., settler and migrant TFs). PIQ 
segregated TFs into pioneers (e.g., AP-1 TF family members), settlers (e.g., NFY and 
RELA subunit of NF-κB) and migrants (e.g., TF RAR family members and SREBF1) 
(Figure 2C). We confirmed this TF hierarchization by inspecting a selection of individual 
TF footprints for their adjacent nucleosomal positioning (Supplementary Figure 2G-I). 
AP-1 family member FOSL1, for example, bound to its cognate binding site despite the 
presence of strongly positioned flanking nucleosomes, as would be expected from a 
pioneer TF (Supplementary Figure 2G), while RELA binding required partial nucleosome 
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displacement/chromatin opening, as would be expected for a settler TF (Supplementary 
Figure 2H), and SREBF1 bound to its cognate site in a near-nucleosome free context, 
as would be expected for a migrant TF (Supplementary Figure 2I). Importantly, there 
was a high correspondence between PIQ predictions and TF ChIP-seq profiling as 
exemplified for AP-1-members FOSL2 and cJUN, which we used as surrogate marks for 
bound AP-1 (which is typically a complex of JUN-JUN or JUN-FOS family member 
dimers), and RELA (Supplementary Figure 2J).  
 To decode additional TF properties critical for shaping the dynamic RAS-OIS 
enhancer landscape, we applied a principal component analysis (PCA) considering 
several metrics describing TF binding characteristics (Figure 2D). This analysis revealed 
two key features: First, pioneer TFs bind statically, extensively, and most importantly 
before RAS-OIS induction (i.e., pre-stimulation) along the genome, while settler and 
migrant TFs bind more dynamically (“Dynamicity” in Figure 2D), far less frequently 
(“Windows” in Figure 2D), and on average less often before OIS induction (i.e. pre-
stimulation) along the genome. Second, and in line with the proposed pioneering activity 
of AP-1 TFs, the latter clearly stand out amongst other pioneer TFs (highlighted by black 
circle in Figure 2D) because they bind exclusively and extensively to enhancers prior to 
RAS-OIS induction whereas most of the remaining pioneer TFs tend to accumulate 
away from them. 
 In summary, we identify de novo enhancer activation and AP-1 as novel and key 
elements that pioneer and shape a transcriptionally permissive enhancer landscape in 
senescence. 
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AP-1 pioneer TF bookmarking of senescence enhancer landscape foreshadows 
the senescence transcriptional program 
Given our unexpected finding that most of the enhancer activation occurred de novo out 
of unmarked chromatin territories, i.e., devoid of enhancer-related histone modifications 
H3K4me1 and H3K27ac and ending in an active H3K4me1+/ H3K27ac+ enhancer state 
at 144h, and that AP-1 TFs act as pioneers to shape the senescence enhancer 
landscape, we explored a possible role of AP-1 as a general bookmarking agent for 
future and past enhancer activity. Quantification of enhancer mark dynamics (Figure 3A 
and Supplementary Figures 3A-C) unveiled that for windows shifting from the 
“unmarked” state at T0 to an “active enhancer” state (H3K4me1+ / H3K27ac+) at either 
72 h or 144 h, i.e. “de novo enhancers”, there is both a gradual increase in H3K4me1 
and H3K27ac levels from initial levels (T0) similar to steady-state unmarked regions but 
different from poised enhancers, to final levels (144 h) indistinguishable from constitutive 
enhancers (Figure 3A and Supplementary Figures 3A-B). By contrast, for windows 
shifting from an “active enhancer” state at T0 to an “unmarked” state at either 72 h or 
144 h, that we refer to as “remnant enhancers”, there is a progressive decrease both in 
H3K4me1 and H3K27ac levels from initial levels indistinguishable from constitutive 
enhancers to final levels similar to unmarked regions and distinct from poised enhancers 
(Figure 3A and Supplementary Figures 3A and 3C). The dynamic behavior of each 
enhancer class on average associated with the expression profile of nearby genes, with 
constitutive enhancers displaying constant gene expression, de novo enhancers 
increasing and remnant enhancers decreasing gene expression (Supplementary Figure 
3D). To directly show the functional role of de novo enhancers we used a CRISPR 
interference (CRISPRi) approach32,33. Expression of 4 different gRNA targeting the 
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dCas9-KRAB transcriptional repressor to de novo enhancers in the IL1α /IL1β genomic 
locus (g7, -14, -15, and -61) significantly reduced the expression of IL1β when analyzed 
8 days after oncogenic RAS induction (Figure 3B). Interestingly, IL1α expression was 
only mildly reduced by the two gRNAs (g61 and g7) adjacent to the IL1β promoter 
(Figure 3B). While similar results were observed 14 days after oncogenic RAS induction 
(Supplementary Figure 3E), a control gRNA (g54) targeting a genomic region just 
downstream of the IL1α /IL1β locus did not affect either expression, while control gRNA 
guides g2 and g48, targeting sequences in-between two de novo enhancers, had only 
very moderate effects (Supplementary Figure 3F). Together, we render ample evidence 
that de novo and remnant enhancers are novel senescence-associated cis-regulatory 
modules that define the senescence transcriptional program.  
 We next determined whether TFs bookmark de novo enhancers for future 
activation and also, whether TFs bookmark remnant enhancers after their inactivation as 
part of a molecular memory. Indeed, as shown in Figure 3C, we found that AP-1 is the 
predominant TF bookmarking de novo and remnant enhancers. Importantly, and 
highlighting the importance of AP-1 in bookmarking de novo enhancers for future 
activation, gRNAs chosen for CRISPRi were either overlapping with AP-1 binding sites 
(g14, g15 and g61) or in close proximity (g7), i.e. ~125bp outside of it (Figure 3B). 
Because CRISPRi can control repression over a length of two nucleosomes (~300bp)34, 
it is highly probable that g7 also affects this AP-1 binding site. Moreover, a control gRNA 
(g2) targeting a non-enhancer AP-1 site (Supplementary Figure 3F) did not affect IL1 
expression strongly suggesting that only enhancer-positioned AP-1 sites are functional. 
Finally, we validated the importance of AP-1 TFs for de novo and remnant enhancer 
bookmarking by examining their positioning also in cells undergoing replicative 
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senescence, which demonstrated that AP-1 TFs here also play a leading role for 
bookmarking (Supplementary Figure 3G). We conclude that AP-1 bookmarking of de 
novo and remnant enhancers is independent of oncogenic RAS signaling and a novel 
and cardinal feature that reflects future and past transcriptional activities in senescence.  
 While performing this analysis, we noticed that only 2,480 out of 3,334 de novo 
enhancers were TF bookmarked, while the remainder (n=854) lacked any detectable TF 
binding activity (Figure 3D). Thus, de novo enhancers can be further divided into two 
subclasses: 1) “TF bookmarked de novo enhancers” and 2) “TF virgin de novo 
enhancers” that are reminiscent to previously described latent enhancers15,35 expanding 
the senescence enhancer landscape. Next, we considered the chromatin state 
environment of the two de novo enhancer classes to further characterize them 
(Supplementary Figure 3H). While a chromatin state environment already rich in 
constitutive enhancers surrounded bookmarked de novo enhancers at T0 (i.e., pre-OIS 
stimulation; left top and bottom plots), a chromatin state environment poor in constitutive 
enhancer elements surrounded virgin de novo enhancers at T0 (right top and bottom 
plots). Both AP-1 bookmarked and virgin de novo enhancers became progressively 
activated and expanded upon RAS-OIS induction. Given that AP-1 premarked de novo 
enhancers operate within pre-existing, active enhancer-rich cis-regulatory regions and 
virgin de novo enhancers in poor ones, we hypothesized that this might impact absolute 
gene expression levels and kinetics upon enhancer activation. Indeed, we observed that 
the nearest genes associated with bookmarked de novo enhancers were already 
expressed at higher basal levels (as were genes proximal to poised enhancers) and 
reached significantly higher absolute expression levels with faster kinetics after RAS-
OIS induction. In contrast, virgin de novo enhancers showed only low-to-background 
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basal expression levels and reached comparatively lower absolute expression levels 
with slower kinetics after RAS-OIS induction (Figure 3E). These results argue that TF 
bookmarking of de novo enhancers, similar to traditional enhancer poising36, is a 
chromatin-priming event that impacts gene expression kinetics and absolute output. 
Contrary to latent enhancers, our newly identified virgin enhancers do not serve an 
adaptive role in mediating stronger and faster gene expression upon restimulation as 
observed in macrophages15, but instead serve as novel enhancer elements for de novo 
gene expression. Finally, we plotted leading gene expression fold-changes against the 
number of de novo enhancers in a given prospective senescence enhancer region. 
Remarkably, we discovered that a single de novo enhancer element of 100 bp can 
substantially activate the expression of its nearest gene and that there exists a positive 
correlation between the number of de novo enhancer elements and the expression 
increase of their nearest genes (Supplementary Figure 3I). 
 Altogether, our results provide compelling evidence that de novo and remnant 
enhancers play a critical role for ensuring that genes pertinent for senescence are 
expressed at the correct time and the correct level and highlight the importance of AP-1 
bookmarking for epigenetic memorization of past and future enhancer activity to define 
the senescence transcriptional program.  
 
A hierarchical TF network defines the senescence transcriptional program  
The combinatorial and dynamic binding of TFs to enhancers and their organization into 
TF networks are central to the spatiotemporal specificity of gene expression and a key 
determinant in cell fate decisions37. TF networks are frequently corrupted in disease and 
thus, a detailed understanding on TF networks has important implications for developing 
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and improving new therapeutic strategies38. Currently, a TF network regulating 
senescence is not available, which precludes a deliberate therapeutic manipulation of 
the senescence phenotype. Importantly, TF networks deduced in silico from the 
integration of time-resolved multidimensional, genome-wide datasets improve the 
accuracy and predictive power of such networks. 
 To elucidate the combinatorial and dynamic binding of TFs to enhancers and their 
organization into TF networks, we first computed co-occurring pairs of TFs in enhancers 
(Figure 4A, Supplementary Figure 4A and Supplementary data: see under Code 
availability in Material and Methods) followed by a topic machine learning approach that 
dissects the complexity of combinatorial binding of many TFs into compact and easily 
interpretable regulatory modules or TF "lexicons" that form the thematic structures 
driving the RAS-OIS gene expression program (Figure 4B)39,40. These analyses 
illustrated two key points. First, as shown in the co-binding matrix of Figure 4A and 
heatmap of Figure 4B, AP-1 pioneer TFs interact genome-wide with most of the 
remaining non-pioneer TFs (i.e., settlers and migrant TFs; Figure 4A), have the highest 
total number of binding sites (Figure 4B, grey colored box plot) and contribute to virtually 
all of the 54 TF lexicons (Figure 4B, green colored boxplot) with lexicon 22 being the 
most frequently represented lexicon genome-wide (Figure 4B, top orange colored box 
plot). Our interactive heatmap of Figure 4B (Supplementary data: see under Code 
availability in Material and Methods) provides a valuable resource for generating new 
hypotheses to functionally dissect TF interactions in cells undergoing RAS-OIS. Second, 
TF lexicon usage associates with specific chromatin states (Supplementary Figure 4B). 
For example, lexicons 21 and 22 are exclusively used for enhancers holding most of the 
AP-1 binding instances, while lexicon 50 is strongly related to polycomb repressor 
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complex (PRC)-repressed regions and lexicons 44 and 52 predominantly associate with 
promoters. Interestingly among the most prominent TFs in lexicon 50 are the known 
PRC-interacting transcriptional co-repressor complex REST and insulator CTCF41,42. 
The latter implies that these proteins may recruit PRC to silence or structure genomic 
regions, an intriguing possibility that deserves further investigation. Moreover, the 
promoter-centric lexicon 52 holds many E2F TFs, which is in line with a primary role of 
E2Fs at promoters43.  
 Next, we developed an algorithm, based on our temporal TF co-binding 
information and a previously published TF network (Supplementary Figure 4C)44, to 
visualize the hierarchical structure of the senescence TF network. In Figure 4C we show 
a representative example of the TF network of SASP gene module VI. The network has 
a three-layered architecture: i) a top layer defined exclusively by the AP-1 family of 
pioneer TFs ii) a core layer composed mostly of other pioneer and settler TFs, and iii) a 
bottom layer characterized by settler and migrant TFs (Figures 4C and Cytoscape 
interactive maps in Supplementary Data: see under Code availability in Material and 
Methods). The core layer itself separates into a multi-level and single-level core, 
depending on the complexity of TF connectivity to the top and bottom layers (Figure 4C). 
Remarkably, the organizational logic of the TF network is highly similar, if not identical, 
for all gene expression modules despite high transcription factor diversity in the core and 
bottom layers (Supplementary data: see under Code availability in Material and 
Methods). The TF network topology for RAS-OIS is congruent with the biochemical and 
dynamic properties of each TF category (i.e., pioneer, settler or migrant) in each layer of 
the network. As the interactions flow from the top to the bottom layer, there is an 
increasing dynamicity and number of TFs and a decreasing number of bound regions 
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(Supplementary Figures 4D-E). Ranking the dynamicity index and the number of bound 
regions for all TFs in each network confirmed the hierarchical principles of their 
organization, with a common core of highly connected TFs from the top and core layers 
shared across all networks (Supplementary Figure 4F, black circle at center). Variability 
in the composition of the most dynamic TFs of the core and bottom layers defines the 
gene expression module specificity for each network and its corresponding specialized 
transcriptional output (Supplementary Figures 4G-I). Thus, TF network topology 
imposes and constrains the position of a given TF in the network and thus, its gene-
regulatory contribution. Our data also revealed unanticipated plasticity in transcription 
factor binding leading to similar gene expression, thus, refuting the simple rule that co-
expression behooves co-regulation45. 
 Our hierarchical TF network model for RAS-OIS enhancers predicted that the 
number of direct target genes regulated by a given TF is a function of its position in the 
TF network hierarchy. To test this prediction, we performed transient RNA interference 
(siRNA) experiments targeting AP-1-cJUN (top layer), ETS1 (multi-level core layer) and 
RELA (single-level core layer) in fully senescent RAS-OIS cells (144 h), determined the 
global transcriptome profiles and compared them to the transcriptomes of cells 
transfected with a non-targeting siRNA (siCTRL) (Figure 4D). Consistent with the TF 
network hierarchy, silencing of AP-1-cJUN affected the most substantial number direct 
gene targets (n=5,089), followed by ETS1 (n=2,431) and RELA (n=2,224), thus, 
confirming the master regulatory role of AP-1 pioneer TFs at enhancers and in the 
execution of the RAS-OIS gene expression program. Specifically, 172 genes were co-
regulated by the three TFs, while 987 were co-regulated by cJUN and ETS1, 520 by 
JUN and RELA, and 293 by ETS and RELA. Correspondence analysis (CA) revealed 
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that perturbing the function of AP-1-cJUN, ETS1 or RELA could separate faithfully (p = 
1.8 x 10-149) up-regulated (V-VII) from down-regulated gene expression modules (I-IV) 
(Figure 4E), which aligns perfectly, both with the CA for chromatin states (see Figures 
2A-B) and the differential impact of the TFs on RAS-OIS-associated enhancer activation 
as predicted in the TF network analysis (Figure 4C and Supplementary data: see under 
Code availability in Material and Methods).  
 We conclude that the senescence response is encoded by a universal three-
layered TF network architecture and relies strongly on the exploitation of an enhancer 
landscape implemented by AP-1 pioneer TFs to choreograph the OIS transcriptional 
program via local, diverse and dynamic interactions with settler and migrant TFs.  
 
Hierarchy Matters: Functional Perturbation of AP-1 pioneer TF, but no other TF, 
reverts the senescence clock  
Pioneer TFs have been identified as important drivers of cell fate changes during 
adaptive and cellular reprogramming as well as in cells undergoing malignant 
transformation46,47. As such, they represent attractive targets to manipulate cell fate for 
diverse research and therapeutic purposes19. 
 The identification of AP-1-cJUN as a principal pioneer TF in fibroblasts 
undergoing RAS-OIS raised the possibility that perturbing its function could considerably 
change the transcriptional trajectory of the OIS cell fate, while perturbation of other TFs 
should not. To test this hypothesis, we depleted AP-1-cJUN, ETS1 and RELA at T0, 72 h 
and 144 h following oncogenic RAS expression and compared global gene expression 
profiles with siCTRL treated cells at identical time-points. Capturing their transcriptional 
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trajectories using PCA illustrated that functional perturbation of ETS1 and RELA shifted 
trajectories along the second principal component (PC2, which captures siRNA-related 
variability) at any given time-point compared to the control time course, but it did not 
affect the timely execution of the RAS-OIS gene expression program, since there is not 
shift along the first principal component (PC1, which captures time-related variability). 
By contrast, perturbing AP-1-cJUN function shifted trajectories both along PC1 and PC2 
and effectively reverted the RAS-OIS transcriptional trajectory to a profile closely related 
to that of siCTRL-treated fibroblasts at 72 h after RAS-OIS induction. Silencing AP-1-
cJUN expression at 72 h also pushed the transcriptional profile closer to control-treated 
cells at day T0 (Figure 5A, blue arrow). Functional overrepresentation analyses of the 
target genes (direct and/or indirect) of each TF further supported the siJUN-mediated 
reversion of the RAS-OIS transcriptional trajectory demonstrating that depletion of AP-1-
cJUN strongly affected both the repression of the inflammatory response (i.e., the 
SASP) and a partial reactivation of pro-proliferation genes (i.e., E2F, G2M and mitotic 
spindle targets) (Figure 5B and Supplementary Figures 5A-C). A complete exit of 
senescence is not expected here, however, as AP-1 is absolutely required for 
proliferation48,49. 
 To quantify and visualize the temporal overlaps in differentially expressed genes 
between siJUN and siCTRL-treated cells we used an UpSet plot (Supplementary 
Figures 5D) and expression heatmaps (Figure 5C and Supplementary Figures 5E-G). 
Congruent with a resetting of the senescence clock, a significant number of pro-
proliferation E2F target genes (14%; e.g. CCNB2 or CDCA8) were up-regulated 
(Supplementary Figure 5E) and NF-κB-regulated SASP target genes (e.g. IL1B or IL6) 
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were down-regulated (60%) (Supplementary Figure 5F). cJUN-depleted RAS-OIS cells 
also shared a similar expression profile for a subset of genes (27%) of the Notch-1 
intracellular domain (NC1ID)-induced senescence (NIS) transcriptional signature50 that 
develops within the first 72-96 h of RAS-OIS (Supplementary Figure 5G). Thus, AP-1 
inhibition is a powerful and save means to potently repress SASP expression in 
senescent cells without affecting their cell cycle arrest. 
 Altogether, these data identify AP-1 as a master regulator and molecular “time-
keeper” of senescence. Our detailed description of the layered TF network architecture 
will facilitate targeted disruption of TFs to manipulate specific features of the 
senescence phenotype for future therapeutic benefit.  
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DISCUSSION  
Exploiting senescence targeting for treating age-related diseases and cancer requires a 
detailed knowledge of the transcriptional, epigenetic, and signaling mechanisms defining 
the basis and realization of the senescence program, which is currently missing. To fill 
this critical gap in our knowledge, we used a dynamic, multidimensional approach at 
high-resolution to define the gene-regulatory code driving the senescence cell fate. 
 A central finding of our study is that the senescence program is defined and driven 
by a predetermined enhancer landscape that is sequentially (in)activated during the 
senescence process. AP1 is instrumental for this predetermination by imprinting a 
prospective senescence enhancer landscape that, in the absence of traditional 
enhancer histone-modification marks, foreshadows future transcriptional activation. This 
is a surprising discovery given that AP-1 transcriptional activation has been traditionally 
linked to growth-factor and MAPK signaling51. There is, however, now accumulating 
evidence that AP-1 also plays an essential role as a pioneering factor for establishing 
cell type-specific enhancers and cellular identities52,53. In line with its role in pioneering 
and bookmarking enhancers, we show that AP-1 is also recruited de novo as a first line 
TF to “virgin” enhancers and that it serves as a molecular memory for enhancers that 
become inactivated during the senescence fate transition that we termed “remnant” 
enhancers. Based on these findings we propose a model by which “enhancer recycling” 
of AP1-bookmarked future and past enhancer activities is an evolutionary conserved 
mechanism that allows for modular and flexible, yet, efficient transcriptional responses 
to incoming signals. We stipulate that the senescence program is preserved through AP-
1 binding to enhancer chromatin as part of epigenetic memory of the cell’s 
developmental (stress) history bypassing histone modification-dependent bookmarking 
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to store genomic information. Further, given the pristine specificity of the newly identified 
prospective and remnant enhancers they can be used as urgently needed specific, 
rather than associated, senescence biomarkers and to predict a cell’s potential to 
undergo senescence. This latter carries also important translational implications for 
identifying cancers that would respond positively to pro-senescence therapy. A natural 
question that arises from our data is whether the senescence program is universal to all 
inducing stimuli and cell types or if multiple senescence programs exist. Based on the 
data presented here and work in progress, we predict that the organizational principles 
of the senescence program we defined here hold for all cell types and inducers. 
Additional time-resolved studies of various inducers in different cell types are required 
and currently ongoing to answer this question definitively. 
 Another key finding is the reversibility of senescence by an informed intervention on 
network topology that we delineated in this study. Indeed, silencing the function of a 
single TF sitting atop the TF network hierarchy, AP-1, is sufficient to revert the 
“senescence clock”. We thus define after the “telomere clock” a second, “epigenomic-
enhancer clock” regulating the senescence process. Why does functional AP-1 
perturbation not lead to complete senescence exit? Based on published49 and our own 
results we surmise that AP1 depletion does not lead to a full cell cycle re-entry and 
proliferation, because AP1 plays important roles for proliferation. Thus, AP1 confines 
cells to their existing proliferative state and therefore may be viewed as a ‘locking 
device’ that restricts cells to their current state. However, we provide compelling 
evidence that functional inhibition of AP1 factors reverts the senescence transcriptional 
program and potently represses the expression of the pro-inflammatory senescence-
associated secretory phenotype (SASP). This finding has great therapeutic potential, as 
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pharmacological interference with AP1 using selective inhibitors (e.g. improved T-5224 
derivatives) would allow to control effectively the detrimental effects of the SASP in 
promoting cancer and other age-related diseases54-56. In summary, we believe that AP1 
is a prime target for therapeutic SASP modulation in vivo. 
 By determining the layered architecture/organizational principles of the TF network 
that orchestrate(s) the transition to OIS, we revealed the plasticity and stability of the 
senescent phenotype. We show that a highly flexible, combinatorial TF interactome 
establishes the senescence program, which is in line with the TF network dynamics 
during hematopoietic and stem cell differentiation57,58. In addition, we demonstrate that 
targeted engineering of specific nodes at different layers of the TF network disrupts 
gene expression with a corresponding magnitude, suggesting a path for the 
manipulation of the senescent phenotype in vivo. Pharmacological inhibition of TFs (see 
above for AP-1), signal transduction molecules, such as kinases or acetylases that 
converge in the activation of TFs, could represent a viable approach for manipulating the 
senescent phenotype in vivo59. Alternatively, small molecules that prevent TF-TF 
combinatorial interactions could also be envisioned60.  
 In conclusion, the present work emphasizes the advantages of, and indeed the need 
for, integrating time-resolved genome-wide profiles to describe and interrogate the 
transition to senescence. This approach generates detailed knowledge necessary to 
develop strategies for manipulating/engineering the senescent cell fate (and other cell 
fate transitions) in vivo for research and therapeutic purposes. Overall, our study 
provides a comprehensive resource for the generation of novel hypotheses regarding 
senescence regulation, offers important mechanistic, regulatory insights that could 
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translate to the study of other cell fate transitions and provide new inroads for the 
diagnosis and manipulation of the senescence state in age-related diseases and cancer. 
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MATERIAL AND METHODS 
Cell culture 
WI-38 fibroblasts (purchased from ECCAC) were cultured in Dulbecco’s Modified 
Eagle’s medium (DMEM) containing 10% FBS and 1X Primocin (Invivogen) at 37ºC and 
3% oxygen. WI-38-ER: RASV12 fibroblasts were generated by retroviral transduction as 
previously described9. Senescence was induced by addition of 400 nM 4-
hydroxytamoxifen (4-OHT, Sigma Cat no. H7904-5MG) to the culture medium and 
samples were collected and processed at the time points indicated in the main text. 
Replicative senescent cells were generated by proliferative exhaustion and were used 
for experiments when cell cultures went through 1 population (PD) per 3 weeks, were 
>80% positive for senescence-associated beta galactosidase activity (SABG) and 
stained negative for EdU (see below for details). For the induction of quiescence, WI-38 
fibroblasts were cultured in DMEM containing 0.2% FBS for up to 4 consecutive days 
and samples were collected and processed as described in the main text. 
 
ATAC-seq 
The transposition reaction and library construction were performed as previously 
described24. Briefly, 50,000 cells from each time point of the senescence time course (2 
biological replicates) were collected, washed in 1X in PBS and centrifuged at 500 x g at 
4ºC for 5 min. Nuclei were extracted by incubation of cells in Nuclear Extraction Buffer 
(NEB) containing 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL 
CA-630 and immediately centrifuging at 500 x g at 4ºC for 5 min. The supernatant was 
carefully removed by pipetting, and the transposition was performed by resuspension of 
nuclei in 50 µL of Transposition Mix containing 1X TD Buffer (Illumina) and 2.5 µL Tn5 
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(Illumina) for 30 min at 37ºC. DNA was extracted using the QIAGEN MinElute kit. 
Libraries were produced by PCR amplification (12-14 cycles) of tagmented DNA using 
the NEB Next High-Fidelity 2x PCR Master Mix (New England Biolabs). Library quality 
was assessed in an Agilent Bioanalyzer 2100. Paired-end sequencing was performed in 
an Illumina Hiseq 2500. Typically, 30-50 million reads per library are required for 
downstream analyses. 
 
Histone modification and transcription factor ChIP-seq 
WI-38-ER: RASV12 fibroblasts were treated with 400 nM 4-OHT for 0, 72 and 144 
hours, and 107 cells (per time point, minimum two biological replicates) were fixed in 1% 
formaldehyde for 15 min, quenched in 2M glycine for additional 5 min and pelleted by 
centrifugation at 2,000 rpm, 4ºC for 4 min. For histone modification ChIP-seq, nuclei 
were extracted in Extraction Buffer 2 (0.25 M sucrose, 10 mM Tris-HCl pH 8.0, 10 mM 
MgCl2, 1% Triton X-100 and proteinase inhibitor cocktail) on ice for 10 min followed by 
centrifugation at 3,000 x g at 4ºC for 10 min. The supernatant was removed and nuclei 
were resuspended in Nuclei Lysis Buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 1% 
SDS and proteinase inhibitor cocktail). Sonication was performed using a Diagenode 
Picoruptor until the desired average fragment size (100-500 bp) was obtained. Soluble 
chromatin was obtained by centrifugation at 11,500 rpm for 10 min at 4ºC and chromatin 
was diluted 10-fold. Immunoprecipitation was performed overnight at 4ºC with rotation 
using 1-2 x 106 cell equivalents per immunoprecipitation using antibodies (5 µg) against 
H3K4me1 (Abcam), H3K27ac (Abcam), H3K4me3 (Millipore), H3K27me3 (Millipore). 
Subsequently, 30 µL of Ultralink Resin (Thermo Fisher Scientific) was added and 
allowed to tumble for 4h at 4ºC. The resin was pelleted by centrifugation and washed 
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three times in low salt buffer (150 mM NaCl, 0.1% SDS, 1% Triton X-100, 20 mM EDTA, 
20 mM Tris-HCl pH 8.0), one time in high salt buffer (500 mM NaCl, 0.1% SDS, 1% 
Triton X-100, 20 mM EDTA, 20 mM Tris-HCl pH 8.0), two times in lithium chloride buffer 
(250 mM LiCl, 1% IGEPAL CA-630, 15 sodium deoxycholate, 1 mM EDTA, 10 mM Tris-
HCl pH 8.0) and two times in TE buffer (10 mM Tris-HCl, 1 mM EDTA). For transcription 
factor ChIP-seq, fibroblasts were treated as described above except that chromatin was 
isolated using the enzymatic SimpleChIP kit (Cell Signaling) according to the 
manufacturer’s instructions, obtaining chromatin with an average fragment length of 4-5 
nucleosomes. Immunoprecipitation was performed overnight at 4ºC with rotation using 
6-10 x 106 cell equivalents per immunoprecipitation using antibodies (5 µg) against 
cJUN, FOSL2 and RELA (Santa Cruz Biotechnologies) and processed as described 
above. Washed beads were resuspended in elution buffer (10 mM Tris-Cl pH 8.0, 5 mM 
EDTA, 300 mM NaCl, 0.5% SDS) treated with RNAse H (30 min, 37 ºC) and Proteinase 
K (2 h, 37ºC), 1 µL glycogen (20 mg/mL, Ambion) was added, and decrosslinked 
overnight at 65 ºC. For histone modifications, DNA was recovered by mixing the 
decrosslinked supernatant with 2.2X SPRI beads followed by 4 min incubation at RT. 
The SPRI beads were washed twice in 80% ethanol, allowed to dry, and DNA was 
eluted by in 35 µL 10 mM Tris-Cl pH 8.0. For transcription factors, DNA was eluted by 
phenol/chloroform extraction (2X) followed by ethanol precipitation overnight at -20ºC. 
The DNA pellet was washed with 70% ethanol, allowed to dry, and DNA was 
resuspended in 35 µL 10 mM Tris-Cl pH 8.0. Histone modification libraries were 
constructed using the NextFlex ChIP-seq kit (Bioo Scientific) according to the 
manufacturer’s instructions. Libraries were amplified for 12 cycles. Transcription factor 
libraries were constructed using a modified protocol from the Accel-NGS 2S Plus DNA 
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Library Kit (#21024), where we performed DNA extraction at each step using 25:24:1 
phenol:chloroform:isoamyl alcohol followed by overnight ethanol precipitation of DNA at 
each step of the protocol. Additionally, we enriched for small DNA fragments using 
AMPure-XP beads (Beckman-Coulter (#A63881).  Libraries were then resuspended in 
20 µL of low EDTA-TE buffer. Libraries were quality controlled in an Agilent 
Technologies 4200 Tapestation (G2991-90001) and quantified using the Invitrogen 
Qubit DS DNA HS Assay kit (Q32854). Libraries were sequenced using an Illumina 
High-Seq 2500. Typically, 30-50 million reads were required for downstream analyses. 
 
RNA and microarrays 
RNA from each time point from the senescence and quiescence time series (2 biological 
replicates) was purified using the QIAGEN RNeasy Plus kit according to the 
manufacturer’s instructions. 100 ng RNA per sample was analyzed using Affymetrix 
Human Transcriptome Arrays 2.0, according to the manufacturer’s instructions.  
 
EdU staining and senescence-associated beta galactosidase activity (SABG)  
Representative samples from the senescent and quiescent time series were evaluated 
for EdU incorporation using the Click-iT EdU Alexa Fluor Imaging Kit (Thermo Fisher 
Scientific) according to the manufacturer’s instructions. SABG activity was assessed as 
previously described61. Cells were imaged in a Zeiss confocal fluorescence microscope 
and images analyzed using the ZEN suite.   
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RNA interference 
Small interfering RNAs (20 µM) targeting JUN (QIAGEN, Ambion), ETS1 (QIAGEN) and 
RELA (QIAGEN) as well as non-targeting controls were transfected into WI-38-ER: 
RASV12 using siIMPORTER reagent (Millipore) according to the manufacturer’s 
instructions (minimum 2 biological replicates per transcription factor per time course 
experiment). RAS-OIS was induced with 400 nM 4-OHT concomitantly with the addition 
of DMEM containing 20% FBS 4 hours after transfection and incubated overnight. 
Sixteen hours after transfection, cells were replenished with new media containing 10% 
FBS and 400 nM 4-OHT, and RNA was isolated at indicated time points and analyzed in 
Affymetrix Human Transcriptome Arrays 2.0.   
 
Expression microarray pre-processing 
Raw Affymetrix HTA 2.0 array intensity data were analyzed using open-source 
Bioconductor packages on R. The quiescence and the RAS-OIS time series data were 
normalized together (2 conditions, 2 biological replicates per condition, 6 time points per 
replicates) using the robust multi-array average normalization approach implemented in 
the oligo package. Internal control probe sets were removed and average expression 
deciles over time-points were independently defined for each treatment. Probes whose 
average expression was lower than the 4th expression decile in both conditions were 
removed for subsequent analyses. To remove sources of variation and account for 
batch effects, data were finally corrected with the sva package. To recover as much 
annotation information as possible, we combined Affymetrix HTA 2.0 annotations 
provided by Affymetrix and Ensembl through the packages hta20sttranscriptcluster.db 
and biomaRt. Principal component analysis and bi-clustering based on Pearson’s 
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correlation and Ward’s aggregation criterion were used to confirm consistency between 
biological replicates and experimental conditions at each step of the pre-processing. 
 
Self-organizing maps (SOM) 
Normalized log-scaled and filtered expression values were processed using the 
unsupervised machine learning method implemented in oposSOM25 to train a self-
organizing map. This algorithm applies a neural network algorithm to project high 
dimensional data onto a two-dimensional visualization space. In this application, we 
used a two-dimensional grid of size 60 x 60 metagenes of rectangular topology. The 
SOM portraits were then plotted using a logarithmic fold-change scale. To define 
modules of co-expressed meta-genes, we used a clustering approach relying on 
distance matrix and implemented in oposSOM. Briefly, clusters of gene expression were 
determined based on the patterns of the distance map which visualizes the mean 
Euclidean distance of each SOM unit to its adjacent neighbors. This clustering algorithm 
– referred to as D-clustering – finds the SOM units referring to local maxima of their 
mean distance with respect to their neighbors. These pixels form halos edging the 
relevant clusters in the respective distance map and enable robust determination of 
feature clusters in the SOM. We finally performed a gene set over-representation 
analysis in each cluster considering the Molecular Signature Database (MSigDB) 
hallmark gene sets using a right-tail modified Fisher’s exact test and the hypergeometric 
distribution to provide p-value. 
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Correlation and multidimensional analyses 
To highlight differences in expression profiles between quiescence and RAS-OIS 
through time, we used multi-dimensional scaling plot representing leading fold change, 
which is defined as the root-mean-square average of the log-fold-changes for the genes 
best distinguishing each pair of samples. To quantify the evolution of transcriptomic 
variability and noise through time, we looked at the gene expression density distributions 
for all possible pairs of treated vs T0 transcriptomes. Distributions were estimated using 
kernel density estimation of all genes’ expression in the  th T0 transcriptome and the th 
treated transcriptome. We also computed Pearson’s correlation for each of these 
combinations. The Pearson’s correlation between two transcriptomes,  and  
containing  gene expressions, is obtained by ,	 
 ∑ 
 
 

	 

 
 
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
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where 
 
 and 
 
 are the  th observation in the vectors  and  respectively, 

 and 

 the 
average values of each transcriptome, and 

 and 

, the corresponding standard 
deviations. 
 
Information theory – derived metrics 
To evaluate transcriptome diversity and specialization, we used an approach based on 
information theory as described in 26.  
 
Gene expression time series analysis 
Normalized log-scaled and filtered expression data related to the quiescence and the 
OIS time series were further considered for differential analysis with limma62. To define 
an RAS-OIS specific transcriptomic signature, we proceeded in three steps, each relying 
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on linear mixed model cubic B-splines, as nonlinear response patterns are commonly 
encountered in time course biological data. For each probe, and each treatment the 
expression was modeled as follow: 
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where 

is the average probe expression over all samples in a given condition, 
	
 the 
model coefficients,  the number of knots, 


 the th knot and  the error term. First, we 
defined probes responding over time to RASV12 induction. Second, we considered all 
together the quiescence and the RAS-OIS time series, as well as the interaction 
between time and treatment, and defined probes responding to one or the other 
treatment over time, as well as probes responding differently between the two 
treatments at any time point. We finally defined the set of probes responding 
consistently to both treatment and time and removed these probes from the global set of 
probes responding to RASV12 induction defined at the first step. Moderated F-statistics 
that combine the empirical Bayes moderated t-statistics for all contrasts into an overall 
test of significance for each probe were used to assess the significance of the observed 
expression changes. At any step of this workflow, p-values were corrected for multiple 
testing using the FDR approach for a stringent significance level of 0.005. For validation 
purposes, we also wanted to compress the RAS-OIS time-series and achieve a volcano 
plot representation. To do so, we’ve computed the maximal absolute log2 fold change in 
expression in the RAS-OIS time series considering T0 as the reference and selected up 
and down regulated probes using an absolute log2 fold change cutoff at 1.2 and a 
corrected p-value cutoff of 0.005. We then build a scatter-plot plotting the log10 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
significance versus log2 fold-change on the y and x axes, respectively. Probes 
responding consistently to both ER: RASV12 induction and quiescence were finally 
over-plotted. 
 
Gene expression unsupervised clustering 
Probes constitutive of the RAS-OIS specific transcriptomic signature were clustered 
using the weighted gene correlated network analysis approach implemented in the 
WGCNA R package63. Standard WGCNA parameters were used for the analysis, with 
the exceptions of soft-thresholding power which was defined using methods described 
by and set at 18. The 7 co-expressed probe clusters identified were further functionally 
characterized using gene set over-representation tests. The same approach as 
previously described for the SOM-defined clusters was used. 
 
Histone modification ChIP-seq data processing 
Reads were cleaned and trimmed using fastq-mcf from the ea-utils suite v1.1.2 to 
remove adapters, low quality bases and reads, and discard reads shorter than 25 bp 
after filtering. Reads were then aligned to the human reference genome (hg19) with 
bowtie v1.1.1 using best matches parameters (bowtie -v 2 -m 1 --best --strata). 
Alignment files were further processed with samtools v1.2 and PicardTools v1.130 to 
flag PCR and optical duplicates and remove alignments located in Encode blacklisted 
regions. Fragment size was estimated in silico for each library using spp v1.10.1. 
Genome-wide consistency between replicates was checked using custom R scripts. 
Enriched regions were identified for each replicate independently with MACS v2.1.0 with 
non-IPed genomic DNA as a control (macs2 callpeak --nomodel --shiftsize --shift-control 
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--gsize hs -p 1e-1). These relaxed peak lists were then processed through the 
irreproducible discovery rate (IDR) pipeline64 to generate an optimal and reproducible 
set of peaks for each histone modification and each time point. 
 
ATAC-seq data processing 
Paired-ends reads were cropped to 100bp with trimmomatic v0.3665 and cleaned using 
cutadapt v1.8.366 to remove Nextera adapters, low quality bases and reads, and discard 
reads shorter than 25 bp after filtering. Fragments were then aligned to the human 
reference genome (hg19) using bowtie2 v2.2.3 discarding inconsistent pairs and 
considering a maximum insert size of 2kb (bowtie2 -N 0 --no-mixed --no-discordant --
minins 30 --maxins 2000). Alignment files were further processed with samtools v1.2 
and PicardTools v1.130 to flag PCR and optical duplicates and remove alignments 
located in Encode blacklisted regions. Accessible regions were identified using MACS2 
v2.1.0 without control (macs2 callpeak --gsize hs -p 1e-3). These relaxed peak lists were 
then processed through the irreproducible discovery rate (IDR) pipeline to generate an 
optimal and reproducible set of peaks for each time point. 
 
Normalized ATAC-seq and ChIP-seq signal tracks 
After verifying the consistency between biological replicates, time points and data type 
using deepTools67, alignments related to biological replicates for a given assay and a 
given time point were combined. We then binned the genome in 200bp non-overlapping 
windows and generated genome-wide read count matrices for each assay 
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independently. These matrices were finally quantile normalized with custom R script and 
further used to generate genome-wide signal tracts. 
 
Histone modification ChIP-seq and ATAC-seq differential analysis 
After assessing library saturation using preseqR, alignment and peak data were 
imported and pre-processed in R using the DiffBind package68. Briefly, for a given 
histone modification type, we first defined the global reproducible peak set as the union 
of each time-specific reproducible peak sets defined previously. We then counted the 
number of reads mapping inside each of these intervals at each time point and for each 
replicate. The raw count matrix was then normalized for sequencing depth using a non-
linear full quantile normalization as implemented in the EDASeq package69. To remove 
sources of unwanted variation and consider batch effects, data were finally corrected 
with the RUVSeq70 package considering 2 surrogate variables. Differential analyses for 
count data were performed using edgeR71 considering time and batch in the design 
matrix, by fitting a negative binomial generalized log-linear model to the read counts for 
each peak. Peaks were finally annotated using ChIPpeakAnno considering annotations 
provided by Ensembl v86.  
 
Chromatin state differential analysis 
To quantify and define combinatorial chromatin state dynamics in space and time, we 
analyzed histone modification combinations with the chromstaR package72. Briefly, after 
partitioning the genome into 100bp non-overlapping bins and counting the number of 
reads mapping into each bin at each time point and for each histone modification, this 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
algorithm relies on a univariate Hidden Markov Model (HMM) with two hidden states 
(unmodified, modified). This HMM is used to fit the parameters of the two-component 
mixture of zero-inflated negative binomial distribution considered to model read counts 
for every ChIP-seq experiments. A multivariate HMM is then used to assign every bin in 
the genome to one of the multivariate components considering 2(3 time points x 4 histone 
modifications)
 possible states. To limit computational burden and focus on accurate 
differences, the analysis was run in differential mode with a 100bp resolution (i.e. 
smaller than a single nucleosome), such that every mark is first analyzed separately with 
all conditions combined while the full combinatorial state dynamics is rebuilt by 
combining the differential calls obtained for the four marks. We finally filtered out 
differential calls not overlapping with any histone modification and ATAC-seq 
reproducible peaks. To properly associate histone modification combinations with 
biologically meaningful mnemonics, we made an extensive comparison between the 
binning we obtained in WI38 fibroblasts undergoing RAS-OIS and IMR90 fetal lung 
fibroblasts chromatin states described in the scope of the Epigenomic Roadmap 
consortium. To test for association between changes in chromatin states through time 
and gene expression modules we ran a correspondence analysis. Briefly, genomic loci 
experiencing changes in chromatin states through time were first associated to the 
nearest gene. We then specifically focused on loci associated to genes belonging to any 
expression module and built a two-way contingency table summarizing the number of 
transition in states (considering all possible combinations) occurring in each expression 
module, further used as an input for a correspondence analysis using FactoMineR73. 
The significance of association between the two qualitative variables (transition in state 
and module) was assed using a 2 test. Results of the CA were visualized using a row-
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metric-preserving contribution asymmetric biplot and filtering for the top contributing and 
well-projected (squared cosine > 0.5) changes in chromatin states. 
 
Motif enrichment analysis in active enhancers 
For each time point independently, we defined the set of active enhancers as the 
overlap between H3K4me1, H3K27ac and ATAC-seq reproducible peaks using 
bedtools74. We then ran 3 independent motif enrichment analyses with homer v4.975 
using default parameters. 
 
Transcription factor footprinting 
All transcription factor Position-Weight Matrices (PWM) representing eukaryote 
transcription factors were downloaded from the JASPAR database and used as an input 
for PIQ21 to predict transcription factor binding sites from the genome sequence on 
down-sampled ATAC-seq alignments. For each motif, we retained only binding sites that 
were within the reproducible ATAC-seq peaks and passed the default purity cut-off 
(70%). We then computed pairwise PWM similarities based on Pearson’s correlation, 
and clustered together PWMs sharing more than 90% similarity, defining a set of 310 
non-redundant and distinct PWMs. The Pearson’s correlation between two PWM   and 
 

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We further combined the bound instances identified with PIQ according to the PWM 
clustering. 
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Transcription factor metrics 
For each transcription factor, we computed the chromatin-opening index (COI), the motif 
dependence and the chromatin dependence (CD) following the approach described in 
21
.  
 
Validation of PIQ predictions through ChIP-seq 
To compare PIQ prediction with RELA, JUN and FOSL2 ChIP-seq data, we first used 
the approach suggested in 21, computing how many of the total ChIP-seq peaks are 
overlapping with any potential factor motif (since ChIP-Seq peaks can result from co-
factor binding, and methods such as digital genomic footprinting are factor agnostic). We 
then used a more sophisticated approach aiming at correlating the ChIP-seq signal 
intensity with the bound / unbound status at PWM matches. For a given transcription 
factor (cJUN, FOSL2 or RELA,), we first considered all the PWM matches located inside 
ATAC-seq reproducible peaks, we selected all the PWM matches assigned with a purity 
score > 0.7 (the threshold used to define “bound” instances), and then randomly 
selected 3 times more PWM matches assigned to a purity score < 0.7 (considered as 
“unbound” instances) to obtain a global set containing 25% / 75% of bound / unbound 
instances for each TF. The selected regions were extended up to 2kb (1kb in each 
direction, from the middle of the match), and the 2kb intervals were binned in one 
hundred 20bp windows. We computed the normalized ChIP-seq and ATAC-seq signal 
inside each bin. The windows were finally ranked according to the summed ChIP-seq 
signal in the 10 most central bins (200bp). We finally run a set enrichment analysis with 
the fgsea package to assess whether bound / unbound PWM matches were enriched / 
depleted along this ranking and computed the enrichment score (ES, positive when 
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bound instances are enriched for highest ChIP-seq signals, negative when unbound 
instances are depleted for highest ChIP-seq signals) and p-values which revealed the 
strength of the correlation. We performed 1,000 permutations to obtain p-values. 
 
Distribution of transcription factor binding sites in space and time 
Using the R package annotatr we first created an annotation datasets combining 
coordinates for hg19 promoters, 3’UTRs, exons, introns and intergenic regions as 
defined in UCSC, as well as our custom set of enhancers (intersection of the global sets 
of reproducible H3K4me1 peaks with global sets of reproducible H3K27ac peaks, to 
focus on enhancers that are active at least in one time point during RAS OIS in WI38 
fibroblasts). We then annotated the PIQ binding occurrences for each of the PWM 
independently, and for the 6 time-points independently. Data were further normalized, to 
account for differences between time-points in the total number of bound occurrences 
summed across PWM, and finally they were converted to frequencies. We filtered TFs 
for which less than 100 binding sites were identified throughout the entire timecourse. 
TFs were ordered according to the proportions of binding sites located in promoters, 
introns or exons, and we finally computed the density in migrant, settler and pioneer 
factors along the ranking. 
 
Transcription factor co-binding 
For every cluster of PWM and time-point independently, we first removed all the bound 
instances identified outside enhancers. The remaining bound instances for all PWM 
were then combined for every time point using GEM regulatory module discovery40  
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
setting at 500 bp the minimal distance for merging nearby TF bound instances into co-
binding regions and at 3 the minimum number of TF bound instances in a co-binding 
region.  
Global pairwise co-binding heatmap. At this step, we obtained a set of contingency 
matrices Mmt of dimension 

#  with i the number of co-binding regions for the 
transcriptomic module m at the time point t and j = 310 PWM clusters, for each time 
point and each transcriptomic module. We then generated module- and time- specific 
normalized pairwise co-binding matrices Cmt by computing the normalized cross-product 
of matrices Mmt defined as: 
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with atmj the number of bound instances for the PWM clusters j, in transcriptomic module 
m, at the time point t. To get a global picture of pairwise co-binding, we summed these 
matrices and tested for each combination of PWM clusters A and B whether the overlap 
between bound instances for A and B was significant using a hyper-geometric test 
defined as: 
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where Q is the overall number of regions in the universe, M is the number of regions 
bound by A, n is the number of regions bound by B, and k the total number of regions 
bound by A and B. The p-values were further corrected for multiple testing using the 
Bonferroni strategy. We finally clustered the co-binding occurrence matrix using Ward’s 
aggregation criterion and projected corresponding corrected q-values on this clustering. 
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Pair-wise co-binding circos plots. To generate the co-binding circos plots, we used the 
global time- and, module-specific pair-wise normalized co-binding matrix Cmt described 
above, after a logarithmic transformation. For each time-point and module 
independently, we selected the top 500 interactions based on their occurrence N. The 
images were generated using the Circos suite76. 
 
Identification of TF regulatory modules 
We used the data-sets generated using GEM regulatory module discovery described 
above. We applied a Hierarchical Dirichlet Process topic model which automatically 
determines the number of topics from the data, with the hyperparameter for the topic 
Dirichlet distribution set at 0.1 (encoding the assumption that most of the topics contains 
a few TFs) and the maximum number of iterations set at 2000. The lexicon usage for 
each time point and each transcriptomic was explored using a multiple factor analysis 
(MFA) with the R package FactoMineR, and lexicons were further selected based on 
their goodness of representation on the 3 first components (squared cosine > 0.5). 
 
TF properties 
With the aim of characterizing the binding properties of each TF, we computed the 
dynamicity, the total number of bound regions, the fraction of bound regions in 
enhancers and the fraction of bound regions before stimulation. 
Dynamicity. We quantified the dynamicity of a TF accordingly to the following 
expression: 
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where 45	 is the dynamicity of TF A; 


5
	
 is the number of regions bound by A for the 
first time at time point 7 ; 7


5
	
 is the number of regions bound by A at time point 7 and 
6

 is the number of regions bound by any TF in time point 7. The factor 6

 was added 
to the expression to account for differences in the number of reads sequenced by the 
ATAC-seq protocol and normalizes the number of regions bound by TF A based on the 
number of bound regions detected at its corresponding time point. Notice that, if all 
samples have the same amount of TF binding events, this expression is reduced to the 
quotient of the sum of the regions first bound at each time point by the sum of all regions 
bound by the TF at each time point. By using this definition, the function 45	 maps the 
activity of a TF to the interval 8 

 
, 19, where :

 is the number of time points in the 
timecourse and is higher as the TF binds to previously not bound regions or leaves 
already bound regions. In the case of a TF that, for every time point, leaves all its 
previous bound regions and binds to only regions not previously bound, the numerator 
will be identical to the denominator, leading to 45	 
 1. Alternatively, if a TF remains on 
the same regions it has bound at 7 
 0 , then ∑


 

 and ∑ 7


 :

; 

 , resulting in 
4

5
	




 
. One can observe that, if the same region is bound by TF A in different time 
points, it will contribute once to the numerator of the expression, while it will contribute to 
the denominator once for each time point it has been bound to. 
Total number of bound regions. The number of bound regions was calculated by the 
following the expression: 
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where 5	 is the normalized number of bound regions by TF A during the timecourse 
and 


5
	, 6

 and :

 are defined as above. The first factor is a normalized sum of the 
regions bound by TF A, counting each region only once. The second factor scales the 
result by the mean of the number of regions bound by all TFs on each day. 
TF percentage of binding at enhancers. The ratio of binding at enhancers, relative to all 
cis regulatory regions, was assessed by: 
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 is the percentage of bound regions in enhancers for TF A, 
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 is the 
number of regions bound by TF A marked as enhancers and 
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 is the number of 
regions bound by TF A marked as promoters. 
TF prestimulation binding. For each TF, we computed the ratio of regions bound at T0, 
relative to the number of regions bound during the whole timecourse. We used the 
following definition for the prestimulation binding factor for each TF: 
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where /5	 corresponds to the prestimulation binding of TF A and 


5
	
 and 6

 are 
defined as above. The numerator of this expression corresponds to the normalized 
number of regions bound by TF A at t = T0, while the denominator is the normalized 
number of regions bound by TF A during the whole timecourse. Notice the denominator 
also corresponds to factor 5	 before scaling. 
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Hierarchical transcription factor network 
In order to assess the TF chromatin binding hierarchy, i.e. TFs required for the binding 
of a specific TF, we generated a network for each gene module depicting the 
precedence of TF chromatin binding. The algorithms mentioned were implemented in R 
and all networks were visualized in CytoScape77.  
Computing precedence relationships. The edges in the generated networks represent 
the precedence relationship of TFs: an oriented edge from TF A to TF B, represented as 
(A, B), means that A was present in at least 30 % of the cis-regulatory regions bound by 
B at the same instant or before44. To account for the difference in the number of reads 
sequenced for each sample in the ATAC-seq, we normalized the number of regions 
bound based on the first day they appeared. The weight of an edge from A to B is given 
by: 
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where 
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 stands for the number of regions first bound by TF B at time point 
 ; 



,
	, for the number of regions first bound by TF B at time point 
 that were bound by 
TF A at time point 
 or before; and 

 represents the total number of regions bound by 
any TF in time point 
. In order to handle the networks, we used the igraph package78. 
Network simplification. Aiming to analyze the hierarchical relationship of TFs and 
simplify the interpretation of the network, we performed two operations over each gene 
module network: Vertex Sort and transitive reduction (TR)79. Briefly, the vertex sort 
algorithm assigns two parameters for each node in the network: the distance, in edges, 
between the node and the bottom of the network; and the distance between the node 
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and the top of the network. Combined, those parameters allow for the topological 
ordering of the network, which consists in listing its nodes such that nodes at the top 
precede downstream nodes. We then defined the ’top layer’ as the set of nodes with 
lowest distance to the top of the network, i.e., nodes that have no incoming edges or 
nodes that assemble a strongly connected component (SCC) with all upstream nodes. 
Analogously, the ’bottom layer’ was defined as the set of nodes with lowest distance to 
the bottom of the network, i.e., nodes with no outgoing edges or that form a SCC with all 
downstream nodes. The ’core layer’ comprises nodes that link top layer and bottom 
layer. Nodes in the core layer that are exactly one edge from both top and bottom layers 
constitute the ’single-level core layer’, while nodes that link top and bottom through 
paths composed of more than one edge form the ’multi-level core layer’. The result of 
this procedure for each gene module can be seen in Figure 4 and supplementary data. 
The TR, in turn, simplifies the network visualization by generating the network with the 
smallest number of edges that keeps the reachability of the original network. 
Network validation. We validated our approach by comparing the network produced 
when applying our method to the ChIP-seq data produced by 44 with the network they 
obtained. Transcription factor ChIP-seq peak files were retrieved from Gene Expression 
Omnibus (GSE36099, 23 TFs, and 4 time points; note that RUNX1 and ATF4 were 
discarded from the analysis since one and three time points, respectively, were missing 
on GEO for those TFs) and preprocessed as previously described to generated time 
resolved co-binding matrices, further used as an input for our networking algorithm. We 
computed the precedence relationships among TFs and generated the TF binding 
hierarchy networks for visualization. We compared the produced TF hierarchy network 
with the network shown in Figure S4 and in 44 using two metrics: sensitivity and 
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specificity. Sensitivity is calculated as the ratio of edges described in this study over the 
edge number sum for both networks. Specificity is defined as the ratio of the number of 
edges that were described to not exist in the network produced by our software over the 
number of edges described to not occur in any of both studies. 
Proportion of incoming edges based on the classification of the TF source node. Aiming 
to assess the hierarchy of TFs accordingly to their chromatin dependence and 
chromatin-opening index, we computed the number of edges connecting the sets of all 
TFs with a given classification for each gene module. We then divided those values by 
the number of edges that target TFs with a specific classification. Hence, the proportion 
of incoming edges based on TF classification is given by: 
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 is the proportion of edges from nodes with classification C1 to nodes with 
classification C2; 
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 is the set of edges from nodes with classification C1 to nodes 
with classification C2;  can represent either pioneer, settler or migrant and || means the 
cardinality of a set, i.e. the number of elements it contains.  
 We assessed the classification precedence significance for TF interaction with a 
hyper-geometric test. We consider the sample space as all possible oriented edges in a 
network with the same number of nodes for each classification as the hierarchy network 
for a given transcriptional module. Formally: 
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 Where is the number of edges on the sample space network, i.e., a fully 
connected network with the same number of nodes as the TF hierarchy network for a 
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given transcriptional module (excluding self-loops),

is the number of edges from 
TFs with classification 1to TFs with classification 2 in the sample space network, 
|

|is the number of edges on the TF hierarchy network for a given transcriptional 
module and |

|is the number of edges in the same network connecting TFs with 
classification 1to TFs with classification 2. 
Network visualization. In order to visualize the network, we exported the adjacency 
matrices in the R environment to CytoScape using the CyREST API80. The networks’ 
layout and style were automated with the help of packages RCy381 and RJSONIO. 
 
Network mining 
With the purpose of identifying key TFs in the transition to the senescent phenotype, we 
analyzed the TF binding characteristics with their relative location in the chromatin 
binding hierarchy networks for each gene module. The figures illustrating this analysis 
were generated with the help of the ggplot2 R package. 
TF classification. For each network relative to a transcriptional gene module, the number 
of TF classified as either pioneer, settler or migrant was calculated for each layer, with 
the subdivision of the core layer as ’multi-level’ and ’single-level’ (see “Network 
simplification”). The overrepresentation of TFs with a specific classification in a given 
layer was evaluated by using a hypergeometric test. We calculated the p-value given by: 
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where K is the number of TFs with a certain classification in the whole network, N is the 
number of TFs in the network; n is the number of TFs that belong to a specific layer and 
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k is the number of TFs that belong to the same layer and have the referred 
classification. The p-values were corrected for multiple testing with FDR and a corrected 
p = 0.05 was considered an indicative of enrichment for that specific classification in the 
corresponding layer. 
TF dynamicity. For each network relative to a transcriptional gene module, we compared 
the distribution of the dynamicity of TFs belonging to a certain layer with the distribution 
of the dynamicity of TFs belonging to the rest of the network. We used the dynamicity 
index defined previously for each TF, considering only the regions marked as enhancers 
belonging only to the gene module relative to the network. For each layer in the network, 
we applied the Kolmogorov-Smirnov test to compare the TF dynamicity distribution for 
the chosen layer with the dynamicity distribution relative to the TFs belonging to three 
other layers in the respective network. To account for multiple hypothesis testing, we 
also performed an FDR correction, considering values of p = 0.05 as an indicative of 
statistical significance. 
TF number of binding regions. We performed the same analysis as described in the 
previous section (“TF dynamicity”) for the number of bound regions defined in section 
“Total number of bound regions”, instead of the dynamicity index. 
TF binding characteristics and transcriptional modules. In order to characterize the 
binding activity of each TF for the different gene modules, we ranked them accordingly 
to their dynamicity and their number of bound regions. Both parameters for each gene 
module are shown in Supplementary Figure 4E, which was generated with the 
ComplexHeatmap82 and circlize83 R packages. We used the mean of the ratio 
dynamicity - number of bound regions to order the TFs. We assessed the significance of 
pioneer (respectively, migrant) TF enrichment at the top (respectively, bottom) of the 
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ranked clustered list by employing a set enrichment analysis implemented in the 
package fgsea. 
TF chromatin binding hierarchy networks overlap. To analyze the similarity between the 
networks for different transcriptional gene modules, we generated a 7-set Euler diagram, 
where each set contains the edges present in the TF hierarchy network relative to a 
gene module. Edges in two different networks are considered equal if they link nodes 
corresponding to the same TFs in their respective networks. We used the package 
Vennerable to compute the intersections of all possible network combinations and to 
create the Euler diagram in Supplementary Figures 4F-I. In this figure, the area of each 
region is proportional to the number of edges shared by the networks corresponding to 
the sets that contain the referred region and was calculated using the Chow-Ruskey 
algorithm84. A Euler diagram is similar to a Venn diagram, with the difference that the 
area of a region representing a set is proportional to the number of elements in the set. 
 
Analysis of de novo and remnant enhancers 
To track combinatorial chromatin state dynamics in space and time, we integrated 
histone modification ChIP-seq signals at a sub-nucleosomal resolution considering non-
overlapping 100bp windows genome-wide using chromstaR (see above), which converts 
quantitative ChIP-seq data to qualitative chromatin states. For subsequent analysis, 
since these 100bp windows can be either isolated or organized in stretches 
experiencing consistent changes in states, we summarized the information at a higher 
level, and linked them with the histone modification peaks identified using the more 
classical ChIP-seq and ATAC-seq peak-calling approach (see flowchart). Briefly, after 
merging all the peaks identified for all the time-points, for all the histone modification and 
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for the ATAC-seq data sets defining cis-regulatory regions, we determined the overlap 
between “poised enhancers“-, “de novo enhancers”-, “remnant enhancer” or “constitutive 
enhancers”-flagged 100bp windows. When an overlap was found, the entire cis-
regulatory regions were annotated according to the 100bp window it is overlapping with. 
This operation rendered a list of annotated cis-regulatory regions with de novo, 
constitutive, poised or remnant enhancer elements. We finally considered the center +/- 
10kb of these elements. 
 
 
 
CRISPR interference (CRISPRi) 
hU6-gRNA-hUbc-dCas9-KRAB plasmid was a kind gift from Charles Gerbach (Addgene 
71236). gRNA cloning was as published 34. Briefly, the plasmid was digested with BsmBI 
and dephosphorylated before ligation with phosphorylated oligo pairs. The gRNA 
sequences were listed in the Table 1. The plasmid was then transfected in HEK293T 
cells, together with packaging plasmids psPAX2 and pMD2.G. 24 hours after fresh 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
medium was added and the medium containing lentivirus was collected and filtered 
subsequently. Cells were infected for 3 hours. 3 days post infection, cells were 
passaged and selected with puromycin and used for analyses. 
 
Table 1. gRNA sequences 
gRNA Sequence 
ctrl caccgGTATTACTGATATTGGTGGG aaacCCCACCAATATCAGTAATACc 
2 caccgAGATGAGGTGTTGCGTGTCT aaacAGACACGCAACACCTCATCTc 
7 caccgTCTGCTCATTGGGGATCGGA aaacTCCGATCCCCAATGAGCAGAc 
14 caccgAAGGCGAAGAAGACTGACTC aaacGAGTCAGTCTTCTTCGCCTTc 
15 caccgCAATGAAATGACTCCCTCTC aaacGAGAGGGAGTCATTTCATTGc 
48 caccgGGAGAACAGTCGCATGAACA aaacTGTTCATGCGACTGTTCTCCc 
54 caccgTTCCAGGGAGTCACCTGTCC aaacGGACAGGTGACTCCCTGGAAc 
61 caccgTTGAAGCAGCACTAGTATCC aaacGGATACTAGTGCTGCTTCAAc 
 
Immunofluorescence staining and imaging of cells 
Immunofluorescence staining was performed as previously published85. Cells grown in 
96-well plates were fixed with 4% PFA and permeabilised with 0.2% Triton-X in PBS. 
After blocking, the cells were incubated with primary antibody for 1 hour, and then Alexa 
Fluor secondary antibody for 30 min. Nuclei were counterstained with DAPI. The 
antibodies were listed in Table 2. The imaging was carried out by IN Cell Analyzer 2000 
(GE Healthcare) with the 20x objective and the quantification was processed using IN 
Cell Investigator 2.7.3 software. 
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Table 2. Antibodies 
Antibody Dilution           Cat. No. 
IL1α 1:100 R&D MAB200 
IL1β 1:100 R&D MAB201 
IL8 1:100 R&D MAB208 
 
 
Quantitative RT-qPCR 
RNA was extracted with TRIzol (Ambion) and RNAeasy Mini Kit (Qiagen) according to 
the manufacturer’s protocol. Reverse transcription was carried out with SuperScript II RT 
kit (Invitrogen). Samples were analysed with SYBR Green PCR Master Mix (Applied 
Biosystems) in CFX96TM Real-Time PCR Detection system (Bio-Rad). Ribosomal 
protein S14 (RPS14) was used as the housekeeping gene. Primers are listed in Table 3. 
 
Table 3. qPCR primer sequence 
Gene Sequence 
RPS14 CTGCGAGTGCTGTCAGAGG TCACCGCCCTACACATCAAACT 
IL1α AGTGCTGCTGAAGGAGATGCCTGA CCCCTGCCAAGCACACCCAGTA 
IL1β GGAGATTCGTAGCTGGATGC AGCTGATGGCCCTAAACAGA 
IL8 GAGTGGACCACACTGCGCCA TCCACAACCCTCTGCACCCAGT 
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Data availability 
All transcriptome data are hosted on Gene Expression Omnibus (BioProject 
PRJNA439263, accession n°GSE112084). ATAC-seq, and ChIP-seq data (histone 
modification and transcription factor) are hosted on SRA (BioProject PRJNA439280). 
 
Code availability for reproducible science 
Interactive maps, circus plots, workflows, scripts and software developed to pre-process 
raw data, perform statistical analyses as well as data mining and integration are 
available as .html, and R Markdown files provided in Supplementary data hosted on 
Zenodo (https://zenodo.org, DOI : 10.5281/zenodo.1493872). This archive collapses all 
the material (including processed data) required to reproduce figures presented in the 
manuscript. 
 
ACKNOWLEDGMENTS 
We thank all members, in particular Nir Rozenblum, of the O.B. laboratory for fruitful 
discussions and suggestions through the course of this work. We would like to thank the 
Transcriptome and Epigenome facility of Institut Pasteur. We thank Claudia Chica for 
expert advice on ChIP-seq data processing. We thank Ido Amit and Deborah Winter for 
valuable discussion and technical support. We thank Benno Schwikowski for key 
insights and technical advice. We also thank Lars Zender, Eric Gilson, and Hinrich 
Gronemeyer for valuable intellectual input. R.I.M-Z. was supported by La Ligue 
Nationale Contre le Cancer and was a Mexican National Scientific and Technology 
Council (CONACYT) and Mexican National Researchers System (SNI) fellow. Lucas 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
Robinson was supported by the Pasteur - Paris University (PPU) International PhD 
Program and by the Fondation pour la Recherche Médicale (FRM). J.A.N.L.F.F. was 
supported by La Ligue Nationale Contre le Cancer.  O.B was supported by the Pasteur-
Weizmann Foundation, ANR-BMFT, Fondation ARC pour la recherche sur le Cancer, La 
Ligue Nationale Contre le Cancer, INSERM-AGEMED. Research reported in this 
publication was supported by the National Cancer Institute of the National Institutes of 
Health under Award Number R01CA136533. The content is solely the responsibility of 
the authors and does not necessarily represent the official views of the National 
Institutes of Health. O.B. is a CNRS Research Director DR2. 
 
AUTHOR CONTRIBUTIONS 
R.I.M-Z, P.-F.R and O.B conceived of the study and conceptual ideas. R.I.M-Z, P.-F.R 
and O.B. planned, designed experiments, interpreted data and wrote the manuscript. All 
authors discussed the results and contributed to the final manuscript. R.I.M-Z generated 
the cell culture system and performed ChIP-seq, ATAC-seq and RNAi experiments. P-
F.R performed computational analyses, designed bioinformatics pipelines and prepared 
figures. L.R. performed senescence characterization studies and performed ChIP-seq 
experiments. J.A.N.L.F.F. generated TF networks. G.D. generated Affymetrix microarray 
data. B.S. and J.G. performed CRISPRi experiments. U.H. supported the study. O.B. 
supervised, managed and obtained funding for the study. 
  
DECLARATION OF INTERESTS 
The authors declare no conflict of interest. 
  
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
REFERENCES 
1. Martinez-Zamudio, R.I., Robinson, L., Roux, P.F. & Bischof, O. SnapShot: 
Cellular Senescence in Pathophysiology. Cell 170, 1044-1044 e1 (2017). 
2. Kirkland, J.L. & Tchkonia, T. Cellular Senescence: A Translational Perspective. 
EBioMedicine 21, 21-28 (2017). 
3. Martinez-Zamudio, R.I., Robinson, L., Roux, P.F. & Bischof, O. SnapShot: 
Cellular Senescence Pathways. Cell 170, 816-816 e1 (2017). 
4. Coppe, J.P., Desprez, P.Y., Krtolica, A. & Campisi, J. The senescence-
associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 
5, 99-118 (2010). 
5. Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its 
potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69 
Suppl 1, S4-9 (2014). 
6. Schosserer, M., Grillari, J. & Breitenbach, M. The Dual Role of Cellular 
Senescence in Developing Tumors and Their Response to Cancer Therapy. Front Oncol 
7, 278 (2017). 
7. Benhamed, M., Herbig, U., Ye, T., Dejean, A. & Bischof, O. Senescence is an 
endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. 
Nat Cell Biol 14, 266-75 (2012). 
8. Shah, P.P. et al. Lamin B1 depletion in senescent cells triggers large-scale 
changes in gene expression and the chromatin landscape. Genes Dev 27, 1787-99 
(2013). 
9. Puvvula, P.K. et al. Long noncoding RNA PANDA and scaffold-attachment-factor 
SAFA control senescence entry and exit. Nat Commun 5, 5323 (2014). 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
10. Rai, T.S. et al. HIRA orchestrates a dynamic chromatin landscape in senescence 
and is required for suppression of neoplasia. Genes Dev 28, 2712-25 (2014). 
11. Tasdemir, N. et al. BRD4 Connects Enhancer Remodeling to Senescence 
Immune Surveillance. Cancer Discov 6, 612-29 (2016). 
12. Sen, P. et al. Histone Acetyltransferase p300 Induces De Novo Super-Enhancers 
to Drive Cellular Senescence. Mol Cell 73, 684-698 e8 (2019). 
13. Heinz, S., Romanoski, C.E., Benner, C. & Glass, C.K. The selection and function 
of cell type-specific enhancers. Nat Rev Mol Cell Biol 16, 144-54 (2015). 
14. Creyghton, M.P. et al. Histone H3K27ac separates active from poised enhancers 
and predicts developmental state. Proc Natl Acad Sci U S A 107, 21931-6 (2010). 
15. Ostuni, R. et al. Latent enhancers activated by stimulation in differentiated cells. 
Cell 152, 157-71 (2013). 
16. van Oevelen, C. et al. C/EBPalpha Activates Pre-existing and De Novo 
Macrophage Enhancers during Induced Pre-B Cell Transdifferentiation and 
Myelopoiesis. Stem Cell Reports 5, 232-47 (2015). 
17. Huggins, C.J. et al. C/EBPgamma suppresses senescence and inflammatory 
gene expression by heterodimerizing with C/EBPbeta. Mol Cell Biol 33, 3242-58 (2013). 
18. Nardella, C., Clohessy, J.G., Alimonti, A. & Pandolfi, P.P. Pro-senescence 
therapy for cancer treatment. Nat Rev Cancer 11, 503-11 (2011). 
19. Drouin, J. Minireview: pioneer transcription factors in cell fate specification. Mol 
Endocrinol 28, 989-98 (2014). 
20. Soufi, A. et al. Pioneer transcription factors target partial DNA motifs on 
nucleosomes to initiate reprogramming. Cell 161, 555-568 (2015). 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
21. Sherwood, R.I. et al. Discovery of directional and nondirectional pioneer 
transcription factors by modeling DNase profile magnitude and shape. Nat Biotechnol 
32, 171-178 (2014). 
22. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse 
embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-76 (2006). 
23. Martin, N. et al. Physical and functional interaction between PML and TBX2 in the 
establishment of cellular senescence. EMBO J 31, 95-109 (2012). 
24. Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y. & Greenleaf, W.J. 
Transposition of native chromatin for fast and sensitive epigenomic profiling of open 
chromatin, DNA-binding proteins and nucleosome position. Nat Methods 10, 1213-8 
(2013). 
25. Loffler-Wirth, H., Kalcher, M. & Binder, H. oposSOM: R-package for high-
dimensional portraying of genome-wide expression landscapes on bioconductor. 
Bioinformatics 31, 3225-7 (2015). 
26. Martinez, O. & Reyes-Valdes, M.H. Defining diversity, specialization, and gene 
specificity in transcriptomes through information theory. Proc Natl Acad Sci U S A 105, 
9709-14 (2008). 
27. Patel, P.L., Suram, A., Mirani, N., Bischof, O. & Herbig, U. Derepression of 
hTERT gene expression promotes escape from oncogene-induced cellular senescence. 
Proc Natl Acad Sci U S A 113, E5024-33 (2016). 
28. Milanovic, M. et al. Senescence-associated reprogramming promotes cancer 
stemness. Nature 553, 96-100 (2018). 
29. Zhang, B. & Horvath, S. A general framework for weighted gene co-expression 
network analysis. Stat Appl Genet Mol Biol 4, Article17 (2005). 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
30. Yosef, N. & Regev, A. Impulse control: temporal dynamics in gene transcription. 
Cell 144, 886-96 (2011). 
31. Deng, T. & Karin, M. c-Fos transcriptional activity stimulated by H-Ras-activated 
protein kinase distinct from JNK and ERK. Nature 371, 171-5 (1994). 
32. Thakore, P.I. et al. Highly specific epigenome editing by CRISPR-Cas9 
repressors for silencing of distal regulatory elements. Nat Methods 12, 1143-9 (2015). 
33. Klann, T.S. et al. CRISPR-Cas9 epigenome editing enables high-throughput 
screening for functional regulatory elements in the human genome. Nat Biotechnol 35, 
561-568 (2017). 
34. Gilbert, L.A. et al. Genome-Scale CRISPR-Mediated Control of Gene Repression 
and Activation. Cell 159, 647-61 (2014). 
35. Kaikkonen, M.U. et al. Remodeling of the enhancer landscape during 
macrophage activation is coupled to enhancer transcription. Mol Cell 51, 310-25 (2013). 
36. Wang, A. et al. Epigenetic priming of enhancers predicts developmental 
competence of hESC-derived endodermal lineage intermediates. Cell Stem Cell 16, 
386-99 (2015). 
37. Zinzen, R.P., Girardot, C., Gagneur, J., Braun, M. & Furlong, E.E. Combinatorial 
binding predicts spatio-temporal cis-regulatory activity. Nature 462, 65-70 (2009). 
38. Wilkinson, A.C., Nakauchi, H. & Gottgens, B. Mammalian Transcription Factor 
Networks: Recent Advances in Interrogating Biological Complexity. Cell Syst 5, 319-331 
(2017). 
39. Neph, S. et al. An expansive human regulatory lexicon encoded in transcription 
factor footprints. Nature 489, 83-90 (2012). 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
40. Guo, Y. & Gifford, D.K. Modular combinatorial binding among human trans-acting 
factors reveals direct and indirect factor binding. BMC Genomics 18, 45 (2017). 
41. Ren, X. & Kerppola, T.K. REST interacts with Cbx proteins and regulates 
polycomb repressive complex 1 occupancy at RE1 elements. Mol Cell Biol 31, 2100-10 
(2011). 
42. Li, T. et al. CTCF regulates allelic expression of Igf2 by orchestrating a promoter-
polycomb repressive complex 2 intrachromosomal loop. Mol Cell Biol 28, 6473-82 
(2008). 
43. Weinmann, A.S., Bartley, S.M., Zhang, T., Zhang, M.Q. & Farnham, P.J. Use of 
chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol 21, 
6820-32 (2001). 
44. Garber, M. et al. A high-throughput chromatin immunoprecipitation approach 
reveals principles of dynamic gene regulation in mammals. Mol Cell 47, 810-22 (2012). 
45. Novershtern, N. et al. Densely interconnected transcriptional circuits control cell 
states in human hematopoiesis. Cell 144, 296-309 (2011). 
46. Zaret, K.S. & Carroll, J.S. Pioneer transcription factors: establishing competence 
for gene expression. Genes Dev 25, 2227-41 (2011). 
47. Jozwik, K.M. & Carroll, J.S. Pioneer factors in hormone-dependent cancers. Nat 
Rev Cancer 12, 381-5 (2012). 
48. Wisdom, R., Johnson, R.S. & Moore, C. c-Jun regulates cell cycle progression 
and apoptosis by distinct mechanisms. EMBO J 18, 188-97 (1999). 
49. Weitzman, J.B., Fiette, L., Matsuo, K. & Yaniv, M. JunD protects cells from p53-
dependent senescence and apoptosis. Mol Cell 6, 1109-19 (2000). 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
50. Hoare, M. et al. NOTCH1 mediates a switch between two distinct secretomes 
during senescence. Nat Cell Biol 18, 979-92 (2016). 
51. Duronio, R.J. & Xiong, Y. Signaling pathways that control cell proliferation. Cold 
Spring Harb Perspect Biol 5, a008904 (2013). 
52. Biddie, S.C. et al. Transcription factor AP1 potentiates chromatin accessibility and 
glucocorticoid receptor binding. Mol Cell 43, 145-55 (2011). 
53. Vierbuchen, T. et al. AP-1 Transcription Factors and the BAF Complex Mediate 
Signal-Dependent Enhancer Selection. Mol Cell 68, 1067-1082 e12 (2017). 
54. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.Y. & Campisi, J. Senescent 
fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and 
aging. Proc Natl Acad Sci U S A 98, 12072-7 (2001). 
55. van Deursen, J.M. The role of senescent cells in ageing. Nature 509, 439-46 
(2014). 
56. Eggert, T. et al. Distinct Functions of Senescence-Associated Immune 
Responses in Liver Tumor Surveillance and Tumor Progression. Cancer Cell 30, 533-
547 (2016). 
57. Tsankov, A.M. et al. Transcription factor binding dynamics during human ES cell 
differentiation. Nature 518, 344-9 (2015). 
58. Goode, D.K. et al. Dynamic Gene Regulatory Networks Drive Hematopoietic 
Specification and Differentiation. Dev Cell 36, 572-87 (2016). 
59. Xu, M. et al. Senolytics improve physical function and increase lifespan in old 
age. Nat Med 24, 1246-1256 (2018). 
60. Overman, J. et al. Pharmacological targeting of the transcription factor SOX18 
delays breast cancer in mice. Elife 6(2017). 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
61. Itahana, K., Campisi, J. & Dimri, G.P. Methods to detect biomarkers of cellular 
senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 
371, 21-31 (2007). 
62. Ritchie, M.E. et al. limma powers differential expression analyses for RNA-
sequencing and microarray studies. Nucleic Acids Res 43, e47 (2015). 
63. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation 
network analysis. BMC Bioinformatics 9, 559 (2008). 
64. Landt, S. G. et al. ChIP-seq guidelines and practices of the ENCODE and 
modENCODE consortia. Genome Res. 22, 1813–31 (2012). 
65. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina 
sequence data. Bioinformatics 30, 2114–20 (2014). 
66. Martin, M. Cutadapt removes adapter sequences from high-throughput 
sequencing reads. EMBnet.journal 17, 10–12 (2011). 
67. Ramírez, F. et al. deepTools2: a next generation web server for deep-sequencing 
data analysis. Nucleic Acids Res. 44, W160–W165 (2016). 
68. Ross-Innes, C. S. et al. Differential oestrogen receptor binding is associated with 
clinical outcome in breast cancer. Nature 481, 389–93 (2012). 
69. Risso, D., Schwartz, K., Sherlock, G. & Dudoit, S. GC-content normalization for 
RNA-Seq data. BMC Bioinformatics 12, 480 (2011). 
70. Risso, D., Ngai, J., Speed, T. P. & Dudoit, S. Normalization of RNA-seq data 
using factor analysis of control genes or samples. Nat. Biotechnol. 32, 896–902 (2014). 
71. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package 
for differential expression analysis of digital gene expression data. Bioinformatics 26, 
139–40 (2010). 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
72. Taudt, A., Nguyen, M. A., Heinig, M., Johannes, F. & Colome-Tatche, M. 
chromstaR: Tracking combinatorial chromatin state dynamics in space and time. bioRxiv 
038612 (2016). doi:10.1101/038612 
73. Lê, S., Josse, J. & Husson, F. FactoMineR: An R package for multivariate 
analysis. 25, 1–18 (2008). 
74. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing 
genomic features. Bioinformatics 26, 841–2 (2010). 
75. Heinz, S. et al. Simple Combinations of Lineage-Determining Transcription 
Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities. 
Mol. Cell 38, 576–589 (2010). 
76. Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. 
Genome Res. 19, 1639–45 (2009). 
77. Shannon, P. et al. Cytoscape: A Software Environment for Integrated Models of 
Biomolecular Interaction Networks. Genome Res. 13, 2498–2504 (2003). 
78. Csárdi, G. & Nepusz, T. The igraph software package for complex network 
research. 
79. Aho, A. V., Garey, M. R. & Ullman, J. D. The Transitive Reduction of a Directed 
Graph. SIAM J. Comput. 1, 131–137 (1972). 
80. Ono, K., Muetze, T., Kolishovski, G., Shannon, P. & Demchak, B. CyREST: 
Turbocharging Cytoscape Access for External Tools via a RESTful API. F1000Research 
4, 478 (2015). 
81. Shannon, P. T., Grimes, M., Kutlu, B., Bot, J. J. & Galas, D. J. RCytoscape: tools 
for exploratory network analysis. BMC Bioinformatics 14, 217 (2013). 
82. Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016). 
83. Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. Circlize implements and 
enhances circular visualization in R. Bioinformatics 30, 2811–2812 (2014). 
84. Chow, S. & Ruskey, F. Drawing Area-Proportional Venn and Euler Diagrams. in 
466–477 (Springer, Berlin, Heidelberg, 2004). doi:10.1007/978-3-540-24595-7_44 
85. Georgilis, A. et al. PTBP1-Mediated Alternative Splicing Regulates the 
Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells. Cancer 
Cell 34, 85–102.e9 (2018). 
 
 
 
 
 
 
 
 
 
 
 
 
 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
FIGURE 1: 
Multi-state establishment of the senescence transcriptional program 
(a) Schematic overview for defining the gene-regulatory code of RAS-OIS using time-
resolved, high-throughput transcriptome (microarray) and epigenome (ChIP-seq, and 
ATAC-seq) data sets.  
(b) Self-organizing maps (SOMs) of gene expression profiles for quiescence and RAS-
OIS time-series experiments as logarithmic fold-change. Red spots mark 
overexpression, blue spots underexpression. 
(c) Multidimensional scaling (MDS) analysis scatter plot visualizing the level of 
similarity/dissimilarity between normalized quiescence and RAS-OIS time-series 
transcriptomes. Distances between samples represent leading logarithmic fold-changes 
defined as the root-mean-squared average of the logarithmic fold-changes for the genes 
best distinguishing each pair of samples. 
(d) Scatter plot depicting the evolution of transcriptome diversity (Hj) vs. transcriptome 
specialization (σj) in cells undergoing quiescence or RAS-OIS. For each time-point and 
treatment, the average Hj and σj values across biological replicates are given. T0 is start 
of time-course. 
(e) Heatmap showing seven modules (I-VII) of temporally co-expressed genes specific 
for RAS-OIS using an unsupervised WGCNA clustering approach. Data are expressed 
as raw Z-scores. 
(f) Functional over-representation map depicting Molecular Signatures Database 
(MSigDB) hallmark gene sets associated to each transcriptomic cluster. Dots are color-
coded according to the FDR corrected p-value based on the hypergeometric distribution. 
Size is proportional to the percentage of genes in the gene set belonging to the cluster. 
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FIGURE 2: 
A dynamic enhancer program shapes the senescence transcriptome 
(a) Arc plot visualizing dynamic chromatin state transitions for the indicated intervals. 
Edge width is proportional to the number of transitions. 
(b) Histogram showing the total number of windows of the top 15 chromatin states 
transitions. Chromatin state transitions corresponding to de novo enhancer activation 
are highlighted as white bars.  
(c) Chromatin dependence (CD) versus chromatin opening index (COI) are plotted for 
high-confidence TF sequence motifs used in our study (see Materials and Methods for 
details). Pioneer, settler and migrant TFs as defined by their COI and CD property are 
color-coded and select members of each TF class are listed. Same color code is used in 
all figures. 
(d) Biplot for principal component analysis performed with select TF binding parameters: 
dynamicity, total number of bound windows (N), percentage of binding at enhancers, 
pioneer index (referred to as the number of bound windows pre-stimulation), chromatin 
opening index (COI) and chromatin dependence (CD). The plot depicts the projections 
of the TFs and the loading of the different covariates for the first two principle 
components which explain 76.9% of the total inertia. The ellipses delineate the 95% 
confidence intervals for AP1 pioneers (blue with black outline), non-AP1 pioneers (blue), 
settlers (red), and migrants (green). 
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FIGURE 3: 
AP-1 pioneer TF bookmarking of senescence enhancer landscape foreshadows 
the senescence transcriptional program 
(a) Distribution of fold-change in normalized enhancer marks H3K27ac and H3K4me1 
ChIP-seq signals over input in the “unmarked”-, “constitutive”-, “poised”-, “de novo”-, and 
“remnant enhancers”-flagged genomic bins at indicated time-points (see Material and 
Methods for details). The cartoon at the top illustrates the temporal rules used to flag 
genomic bins. Bottom specifies the genomic coverage in mega bases (Mb) for each 
category and the corresponding number of enhancers. 
(b) WI38-ER: RASV12 were super-infected with dCas9-KRAB and individual guides 
(g14, 15, g61 and g7) targeting two de novo enhancers. Cells were pharmacologically 
selected and induced into RAS-OIS by 4-OHT. 8 days after RAS-OIS induction cells 
were stained by indirect immunofluorescence for IL1β or analyzed by RT-qPCR for the 
expression of IL1α or IL1β. WI38-ER: RASV12 treated with 4-OHT or DMSO served as 
positive and negative controls. Data represent mean ± SD (n=3). *p<0.05, ***p<0.001. 
Comparison with ctrl 4-OHT, one-way ANOVA (Dunnett’s test). Scale bar, 100 µm. 
(c) Rank plot depicting the summed occurrences for TF binding in de novo enhancers 
before RAS-OIS induction (left) and remnant enhancers after RAS-OIS (6 days) 
induction (right). Top ten TFs are indicated. 
(d) Distribution of total number (N) of TFs bound per enhancer for constitutive 
enhancers (grey), TF pre-marked de novo enhancers (yellow) and TF virgin de novo 
enhancers (orange). 
(e) Average absolute expression level (log2 scale) kinetics for genes associated with: 
poised (blue), TF pre-marked de novo (yellow), and TF virgin de novo enhancers 
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(orange). Dots depict the average absolute expression level, and bars depict the 
standard error of the mean. Inset histogram illustrates the average leading log2 fold-
change in expression (+/- standard error of the mean) for genes associated with 
constitutive (black), poised (light blue), TF pre-marked de novo (yellow) and TF virgin de 
novo (orange), and remnant enhancers (dark blue). 
 
FIGURE 4: 
A hierarchical TF network defines the senescence transcriptional program 
(a) Genome-wide transcription factor co-binding occurrence matrix summed across all 
time-points (left, shades from blue to yellow, in log10 scale). Overlap significance was 
calculated by a hyper-geometric test (right, shades from blue to red, in -log10 scale). The 
co-binding occurrence matrix was clustered using Ward’s aggregation criterion and 
corresponding, corrected q-values were projected on this clustering. The graphs on the 
left and bottom show the density in pioneer, migrant and settler TFs along each axis of 
the matrix. 
(b) Heatmap describing the association between individual TFs (row) and TF lexicons 
(columns). Four boxed out insets provide detailed information on TF composition of 
lexicons. A comprehensive, high-resolution and interactive heatmap is shown in 
Supplementary Data (see under Code availability in Material and Methods). The right 
bar plot shows the total number of binding sites for each TF. The top bar plot shows the 
total number of regions for each regulatory module. The bottom bar plot shows the 
average proportion of AP1 binding sites inside each regulatory module. 
(c) Graphical representation of the hierarchical TF network for transcriptomic module VI. 
Nodes (circles) represent TFs and an oriented edge (line) connecting TFs A and B 
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means that at least 30 % of the regions bound by B were also bound by A at the same 
time point or before. In order to simplify the visualization, we represent strongly 
connected components (SCCs) as a single node and performed a transitive reduction 
(TR). Node color is based on the average dynamicity of the SCC members. Node border 
color indicates their classification as pioneer (blue), settler (red) or migrant (green). 
Node border thickness encodes the percentage of bound regions before RAS 
stimulation. Edge color was calculated accordingly to the relative coverage of the 
outgoing TF over the incoming TF. The network has three layers: top, core and bottom. 
Nodes in the top have no incoming edges and nodes in the bottom have no outgoing 
edges. The core layer comprises TFs that have both incoming and outgoing edges. 
Interactive Cytoscape graphs are accessible as Supplementary data (see under Code 
availability in Material and Methods). 
(d) Venn diagram showing the specificities and overlaps in differentially expressed direct 
target genes upon siRNA-mediated AP-1-cJUN, ETS1, and RELA depletion in RAS-OIS 
cells at day 6 (fully senescent cells). Genes are considered as direct targets of a given 
TF when PIQ predicts that the TF bound to an enhancer associates to this gene (see 
Materials and Methods for details). Promoters were excluded from the analysis. 
(e) Asymmetric biplot for correspondence analysis between transcriptomic clusters and 
the number of up-, down-, up-or-down- or nonregulated (stable) genes upon siRNA-
mediated AP-1-cJUN, ETS1 or RELA depletion. The p-value reflects the strength of the 
association as assessed with a 2 test. 
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FIGURE 5: 
Hierarchy Matters: Functional Perturbation of AP-1 pioneer TF, but no other TF, 
reverts the senescence clock 
(a) Principal component analysis (PCA) on transcriptomes obtained from siRNA-
mediated depletion of AP-1-cJUN, ETS1 or RELA at indicated timepoints of the RAS-
OIS timecourse. Horizontal and vertical bars show minimal and maximal coordinates for 
each siRNA and time-point on principal components one (PC1, horizontal axis) and two 
(PC2, vertical axis). 
(b) Functional overrepresentation map showing Molecular Signature Database 
(MSigDB) hallmark pathways associated to “All, Direct Target and Indirect Target” genes 
differentially expressed after siRNA-mediated AP-1-cJUN, ETS1 or RELA depletion. 
Genes are considered as direct targets when a PIQ prediction for the given TF is falling 
inside an enhancer associated to this specific gene. Promoters are excluded from the 
analysis. The size of dots is proportional to the -log10 q-value based on the 
hypergeometric distribution obtained when testing for over-representation, and their 
color denote whether the term is enriched for an up or down-regulated gene list. 
(c) Heatmap comparing gene expression profiles of siRNA-Control-treated (siCTRL) 
cells at indicated time-points of OIS and siRNA-cJUN treated senescent RAS-OIS cells 
at day 6 (144h). 
 
Figure S1: 
Multi-state establishment of the senescence transcriptional program 
(a-b) Characterization of quiescence and RAS-OIS cells. (a) Representative DAPI, EdU, 
SABG (from left to right) indirect fluorescence and phase contrast microscopy images of 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/633594doi: bioRxiv preprint first posted online May. 9, 2019; 
WI38 fibroblasts undergoing quiescence at indicated time-points. Proliferative capacity is 
% of EdU-positive staining cells. Scale bar, 100µm. (b) Representative DAPI, EdU, 
SABG (from left to right) indirect fluorescence and phase contrast microscopy images of 
WI38 fibroblasts undergoing OIS at indicated time-points. Scale bar, 100µm. 
(c) Distribution of gene expression levels as kernel density estimates for time-resolved 
quiescence and RAS-OIS transcriptomes. Pearson’s correlation coefficient (R2) is 
shown. 
(d) Volcano plot of RAS-OIS time-series transcriptome data. Dark grey dots highlight 
genes sharing a common gene expression pattern between quiescence and OIS time-
series experiments and were removed to define the RAS-OIS specific temporal 
transcriptomic signature used for all further downstream analyses. 
(e) Boxplot depicting expression patter for each of the RAS-OIS transcriptomic modules. 
Data are expressed as row Z-score. 
 
Figure S2: 
A dynamic enhancer program shapes the senescence transcriptome 
(a) Histogram showing the percentage of genome covered by each chromatin state at 
indicated time. Bottom table assigns histone modification combinations (grey: presence, 
white: absence) to biologically meaningful mnemonics. Venn diagrams highlight the 
specificities and overlaps in chromatin states associated with active (left) and poised 
enhancers (right) at indicated time-points. 
(b) Boxplots showing the distribution of relative gene expression (row Z-score) through 
time for genes associated to regions undergoing different chromatin state changes. The 
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pictogram at the top of each graph describes the class of chromatin state change 
considered. 
(c) Asymmetric biplot for correspondence analysis between changes in chromatin states 
and gene expression modules. The p-value reflects the strength of the association using 
a 2 test. Only the top 20 contributing and best projected (squared cosine > 0.5) 
chromatin state changes are shown. 
(d-f) Most enriched sequence motifs in (d) active enhancers or (e-f) ATAC-seq peaks at 
each time point for the (d) RAS-OIS, (e) replicative senescence, and (f) quiescence time 
courses. (d) Motif logos are shown on left of the histogram. Black, dotted boxes highlight 
the core motif for AP1 transcription factor family members. Note that the transcriptional 
repressor BACH shares this motif. 
(g-i) ATAC-seq (grey lines for forward, black lines for reverse reads) and nucleosome 
(red line) footprints for (g) AP-1 FOSL1 (pioneer), (h) RELA (settler), and (i) SREBF1 
(migrant). 
(j) Comparison between PIQ predictions and RELA (left), AP-1-JUN (middle) and AP-1-
FOSL2 (right) ChIP-seq. The two density heatmaps at the center of each panel illustrate 
ChIP-seq (left) and ATAC-seq (right) signals computed in 10bp non-overlapping 
windows at selected bound- (25%) and unbound- (75%) predicted PWM hits ± 1kb 
ranked according to the ChIP-seq signal in the most central 100bp. The stack histogram 
on the left shows the distribution of bound (red) and unbound (green) PWM hits as 
defined by PIQ along the ranking. The curves on the right depict the evolution of the 
enrichment score (ES) along the ranking as defined with a set enrichment analyses 
(SEA) comparing the ChIP-seq signal and the bound (red) and unbound (green) status 
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of the PWM hit. For each SEA, we performed 1 000 permutations and provide the 
associated Benjamini–Hochberg adjusted p-value and ES score. 
 
Figure S3: 
AP-1 pioneer TF bookmarking of senescence enhancer landscape foreshadows 
the senescence transcriptional program 
(a) Density heatmaps of normalized H3K27ac and H3K4me1 ChIP-seq signals 
computed in 10bp non-overlapping windows at enhancers +/- 10kb grouped by 
enhancer status (constitutive, de novo or remnant) at indicated time-points after RAS-
OIS induction. 
(b-c) Representative genome browser screenshots of normalized H3K4me1 (pink), 
H3K27ac (orange), H3K4me3 (blue) and H3K27me3 (green) ChIP-seq and ATAC-seq 
(light grey) profiles and chromatin states at (b) IL1ß and (c) CDC6 gene loci. Red boxes 
single-out (b) IL1ß de novo and (c) CDC6 remnant enhancers. 
(d) Boxplots depicting the distribution of relative gene expression (row Z-score) through 
time for genes associated with constitutive (left), de novo (middle) and remnant (left) 
enhancer windows. 
(e) RAS-OIS cells at day 14 infected with dCas9-KRAB and individual guides (g14, g15, 
g61, and g7) and analyzed by RT-qPCR for the expression of IL1α or IL1β as described 
in Figure 3b. Data represent mean ± SD (n=3). *p<0.05, ***p<0.001. Comparison with 
ctrl 4OHT, one-way ANOVA (Dunnett’s test). 
(f) RAS-OIS cells were infected with dCas9-KRAB and individual guides (g2, g48 and 
g54) for non-enhancer regions (outside de novo enhancers) as described in Figure 3b. 8 
or 14 days after infection, cells were stained for IL1α or IL1β by indirect 
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immunofluorescence and percentage positive cells were quantified (n=3 for 8 days and 
n=2 for 14 days). Data represent mean ± SD. *p<0.05, **p<0.01, ***p<0.001. 
Comparison with ctrl 4OHT, one-way ANOVA (Dunnett’s test). 
(g) Rank plot depicting the summed occurrences for TFs binding in proliferating cells 
(T0) in de novo enhancers (left) and after replicative senescence in remnant enhancers 
(right). Top ten TFs are highlighted. 
(h) Metaprofiles showing the density in “active enhancer”-flagged genomic bins (top) 
and “constitutive enhancer”-flagged genomic bins (bottom) in the vicinity (+/- 50kb) of TF 
bookmarked de novo (left) and TF virgin de novo enhancers (right). The density in 
“active enhancer”-flagged genomic bins is provided for the indicated time points. 
(i) Boxplot showing the correlation between absolute leading log2 expression fold-
change and the number of genomic bins flagged as “de novo” enhancers per enhancer. 
*** : p-value < 10-3, Student’s t-test considering regions with 0 “de novo” enhancers bins 
as a control. 
 
Figure S4: 
A hierarchical TF network defines the senescence transcriptional program 
(a) Representative circos plots summarizing pairwise transcription factor co-binding at 
enhancers for down-regulated transcriptomic module (IV, top) and up-regulated 
transcriptomic module (VI, bottom) at indicated time-points. Co-interactions involving 
AP1 are shown in black. Selected examples of gained (green) and lost (orange) 
interactions are highlighted. Pioneer TFs blue, settler TFs red, migrant TFs green. See 
also dynamic circos plot movies in Supplementary Data (see under Code availability in 
Material and Methods). 
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(b) Heatmap showing the overlap between TF lexicons (rows) and chromatin states, 
ChIP-seq and ATAC-seq peaks (columns). The dendrograms were computed by 
applying hierarchical clustering on the fraction matrix with Pearson’s correlation and 
average linkage. 
(c) Validation of TF network algorithm using TF ChIP-seq published data sets (Garber et 
al., 2012). Edges colored in gray were detected in both studies and edges colored in red 
were found only the analysis performed by Garber et al.. The displayed edge set is the 
same as in Figure 5A (Garber et al., 2012). We employed a transitive reduction step in 
order to facilitate visualization. Comparison of the two networks resulted in a sensitivity 
of 88,9 % and a specificity of 100 %. 
(d) Ratio of incoming edges based on the classification of the TF source node. The 
relative and absolute number of edges corresponding to all seven modules are 
displayed inside the nodes, which are colored accordingly to TF classification as in 
previous panels. The thickness of links is proportional to the relative number of TF 
hierarchy edges connecting nodes with the corresponding classification. 
(e) Number of bound regions and dynamicity index for each TF (rows) across all gene 
modules (columns). The left heatmap depicts the dynamicity index scaled by column. 
The middle heatmap depicts the square root of number of bound regions scaled by 
column. The right single-column heatmap illustrates TF classification. 
(f) Venn diagram showing specificities and overlaps of TF interactions in each gene 
module. Each set corresponds to the TF-TF network edges identified for a given 
transcriptomic module. The global area of each set is proportional to the number of 
edges in its respective transcriptomic module and was calculated with the Chow- 
Ruskey algorithm. 
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(g-i) Chow-Ruskey diagrams for edges (g) originating only from TFs at the top of 
hierarchy, (h) connecting only TFs at the core layer or (i) reaching only TFs at the 
bottom. Note that edges at the top of the hierarchy are shared among the gene modules 
while edges towards the bottom of the hierarchy are module-specific.  
 
Figure S5: 
Hierarchy Matters: Functional Perturbation of AP-1 pioneer TF, but no other TF, 
reverts the senescence clock 
(a-c) Volcano plots depicting the -log10 p-value as a function of the log2 fold-change in 
gene expression defined by a differential analysis conducted with limma to highlight the 
effect of siRNA-mediated (a) AP-1-cJUN, (b) ETS1 and (c) RELA depletion in senescent 
RAS-OIS cells at day 6 (144h). Blue dots in respective plots indicate probes 
corresponding to AP-1-cJUN, ETS1 and RELA. Black outlined dots highlight direct 
targets of AP-1-cJUN, ETS1 and RELA. 
(d) Upset plot depicting specificities and overlaps in differentially expressed genes of 
siRNA-Control and siRNA-JUN silenced OIS fibroblasts at indicated time-points. The 
yellow dots highlight gene sets specific to a single comparison set, while green dots 
highlight gene sets find in two different pair-wise comparison. 
(e-g) Venn diagrams (top) and heatmaps (bottom) depicting the overlap between genes 
belonging to (e) E2F-, (f) NFκB target, and (g) N1ICD-induced senescence (NIS) gene 
signatures. Venn diagrams show the overlap of up-regulated genes after siRNA-
mediated AP-1-cJUN knock-down for upregulated E2F- (i.e. pro-proliferation genes), 
NIS- (i.e. early SASP genes), and downregulated NFκB target genes (i.e. late SASP 
genes) RAS-OIS cells at day 6 (144h). Bottom heatmaps show the comparison of gene 
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expression profiles of siRNA-Control (siCtrl) and siRNA-cJUN treated cells undergoing 
RAS-OIS at indicated time-points. Data are expressed as row Z-score. E2F targets and 
NFκB targets were defined according to Molecular Signature Database (MSigDB). 
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